UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 10-Q


[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended JuneSeptember 30, 2019
or

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934

For the transition period from _________ to __________

COMMISSION FILE NUMBER 1-33926
trecoralogoa02.jpg
TRECORA RESOURCES
(Exact name of registrant as specified in its charter)

DELAWARE75-1256622
(State or other jurisdiction of(I.R.S. Employer Identification No.)
incorporation or organization) 
1650 Hwy 6 South, Suite 19077478
Sugar Land, Texas(Zip code)
(Address of principal executive offices) 

Registrant's telephone number, including area code: (281) 980-5522

N/A
Former name, former address and former fiscal year, if changed since last report.

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.10 per shareTRECNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes   X   No       

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S–T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   X   No      
 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer          Accelerated filer   X   

Non-accelerated filer        Smaller reporting company      

Emerging growth company     

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.____

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes      No   X   

Number of shares of the Registrant's Common Stock (par value $0.10 per share), outstanding at July 31,October 29, 2019: 24,714,980.



TABLE OF CONTENTS

Item Number and Description
 
 
 
 
 
 
 
 
   
   
   
 
 
 
 
   
   
   



PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
 June 30,
2019
(Unaudited)
 December 31,
2018
 September 30,
2019
(Unaudited)
 December 31,
2018
ASSETS (thousands of dollars, except par value) (thousands of dollars, except par value)
Current Assets        
Cash $4,325
 $6,735
 $9,157
 $6,735
Trade receivables, net 30,518
 27,112
 25,497
 27,112
Inventories 15,295
 16,539
 13,285
 16,539
Investment in AMAK (held-for-sale) 34,090
 38,746
Prepaid expenses and other assets 3,951
 4,664
 3,726
 4,664
Taxes receivable 182
 182
 182
 182
Total current assets 54,271
 55,232
 85,937
 93,978
        
Plant, pipeline and equipment, net 191,528
 194,657
 190,345
 194,657
        
Goodwill 21,798
 21,798
 21,798
 21,798
Intangible assets, net 18,016
 18,947
 17,551
 18,947
Investment in AMAK 37,265
 38,746
Lease right of use assets, net 15,197
 
Lease right-of-use assets, net 14,364
 
Mineral properties in the United States 558
 588
 562
 588
        
TOTAL ASSETS $338,633
 $329,968
 $330,557
 $329,968
LIABILITIES        
Current Liabilities        
Accounts payable $11,159
 $19,106
 $10,203
 $19,106
Accrued liabilities 5,415
 5,439
 7,270
 5,439
Current portion of long-term debt 4,194
 4,194
 4,194
 4,194
Current portion of lease liabilities 3,412
 
 3,247
 
Current portion of other liabilities 850
 752
 1,011
 752
Total current liabilities 25,030
 29,491
 25,925
 29,491
        
Long-term debt, net of current portion
 94,191
 98,288
 85,143
 98,288
Lease liabilities, net of current portion
 11,785
 
 11,117
 
Other liabilities, net of current portion
 1,047
 1,352
 906
 1,352
Deferred income taxes 16,623
 15,676
 16,646
 15,676
Total liabilities 148,676
 144,807
 139,737
 144,807
        
EQUITY        
Common stock‑authorized 40 million shares of $0.10 par value; issued 24.7 million and 24.6 million in 2019 and 2018 and outstanding 24.7 million and 24.6 million shares in 2019 and 2018, respectively
 2,472
 2,463
Common stock‑authorized 40 million shares of $0.10 par value; issued and outstanding 24.7 million and 24.6 million in 2019 and 2018, respectively
 2,472
 2,463
Additional paid-in capital 58,920
 58,294
 59,202
 58,294
Common stock in treasury, at cost (2) (8) (2) (8)
Retained earnings 128,278
 124,123
 128,859
 124,123
Total Trecora Resources Stockholders' Equity 189,668
 184,872
 190,531
 184,872
Noncontrolling Interest 289
 289
 289
 289
Total equity 189,957
 185,161
 190,820
 185,161
        
TOTAL LIABILITIES AND EQUITY $338,633
 $329,968
 $330,557
 $329,968

See notes to consolidated financial statements.

  
 1 




TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOMEOPERATIONS (UNAUDITED)
 THREE MONTHS ENDED
JUNE 30,
 SIX MONTHS ENDED
JUNE 30,
 THREE MONTHS ENDED
SEPTEMBER 30,
 NINE MONTHS ENDED
SEPTEMBER 30,
 2019 2018 2019 2018 2019 2018 2019 2018
 (thousands of dollars, except per share amounts) (thousands of dollars, except per share amounts)
REVENUES                
Product sales $65,329
 $63,569
 $126,822
 $130,268
 $59,111
 $68,613
 $185,933
 $198,881
Processing fees 4,042
 4,537
 7,704
 9,579
 3,604
 4,803
 11,308
 14,382
 69,371
 68,106
 134,526
 139,847
 62,715
 73,416
 197,241
 213,263
                
OPERATING COSTS AND EXPENSES                
Cost of sales and processing                
(including depreciation and amortization of $4,128, $2,837, $8,357 and $5,667, respectively) 58,806
 59,964
 113,888
 121,565
(including depreciation and amortization of $3,254, $3,813, $11,611 and $9,480, respectively) 53,148
 66,574
 167,036
 188,139
                
GROSS PROFIT
 10,565
 8,142
 20,638
 18,282
 9,567
 6,842
 30,205
 25,124
                
GENERAL AND ADMINISTRATIVE EXPENSES                
General and administrative 6,081
 4,554
 12,131
 10,889
 6,401
 6,327
 18,532
 17,216
Depreciation 208
 191
 421
 387
 208
 205
 629
 592
 6,289
 4,745
 12,552
 11,276
 6,609
 6,532
 19,161
 17,808
                
OPERATING INCOME 4,276
 3,397
 8,086
 7,006
 2,958
 310
 11,044
 7,316
                
OTHER INCOME (EXPENSE)                
Interest income 
 14
 5
 21
 
 5
 5
 26
Interest expense (1,401) (815) (2,900) (1,693) (1,211) (924) (4,111) (2,617)
Equity in (losses) earnings of AMAK (91) 228
 (150) 458
Loss on Extinguishment of Debt 
 (315) 
 (315)
Miscellaneous income (expense), net 284
 (13) 256
 (39) 74
 (28) 330
 (67)
 (1,208) (586) (2,789) (1,253) (1,137) (1,262) (3,776) (2,973)
                
INCOME BEFORE INCOME TAXES 3,068
 2,811
 5,297
 5,753
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 1,821
 (952) 7,268
 4,343
                
INCOME TAX EXPENSE 664
 596
 1,142
 1,186
INCOME TAX EXPENSE (BENEFIT) 238
 (236) 1,412
 854
                
NET INCOME 2,404
 2,215
 4,155
 4,567
INCOME (LOSS) FROM CONTINUING OPERATIONS 1,583
 (716) 5,856
 3,489
                
NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST 
 
 
 
LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX (1,002) (893) (1,120) (531)
                
NET INCOME ATTRIBUTABLE TO TRECORA RESOURCES $2,404
 $2,215
 $4,155
 $4,567
NET INCOME (LOSS) $581
 $(1,609) $4,736
 $2,958
                
Basic Earnings per Common Share                
Net income attributable to Trecora Resources (dollars) $0.10
 $0.09
 $0.17
 $0.19
Net income (loss) from continuing operations (dollars) $0.06
 $(0.03) $0.24
 $0.14
Net loss from discontinued operations, net of tax (dollars) (0.04) (0.04) (0.05) (0.02)
Net income (loss) (dollars) $0.02
 $(0.07) $0.19
 $0.12
                
Basic weighted average number of common shares outstanding 24,696
 24,370
 24,675
 24,354
 24,717
 24,483
 24,689
 24,397
                
Diluted Earnings per Common Share                
Net income attributable to Trecora Resources (dollars) $0.10
 $0.09
 $0.17
 $0.18
Net income (loss) from continuing operations (dollars) $0.06
 $(0.03) $0.23
 $0.14
Net loss from discontinued operations, net of tax (dollars) (0.04) (0.04) (0.04) (0.02)
Net income (loss) (dollars) $0.02
 $(0.07) $0.19
 $0.12
                
Diluted weighted average number of common shares outstanding 25,091
 25,014
 25,089
 25,119
 25,053
 25,175
 25,077
 25,138

See notes to consolidated financial statements.

  
 2 




TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)
THREE MONTHS ENDED JUNESEPTEMBER 30
 TRECORA RESOURCES STOCKHOLDERS     TRECORA RESOURCES STOCKHOLDERS    
 COMMON STOCK 
ADDITIONAL
PAID-IN
 TREASURY RETAINED   
NON-
CONTROLLING
 TOTAL COMMON STOCK 
ADDITIONAL
PAID-IN
 TREASURY RETAINED   
NON-
CONTROLLING
 TOTAL
 SHARES AMOUNT CAPITAL STOCK EARNINGS TOTAL INTEREST EQUITY SHARES AMOUNT CAPITAL STOCK EARNINGS TOTAL INTEREST EQUITY
 (thousands)
 (thousands of dollars) (thousands)
 (thousands of dollars)
March 31, 2019 24,687
 $2,469
 $58,565
 $(8) $125,874
 $186,900
 $289
 $187,189
June 30, 2019 24,715
 $2,472
 $58,920
 $(2) $128,278
 $189,668
 $289
 $189,957
                                
Restricted Stock Units                                
Issued to Directors 
 
 146
 
 
 146
 
 146
 
 
 96
 
 
 96
 
 96
Issued to Employees 
 
 209
 
 
 209
 
 209
 
 
 186
 
 
 186
 
 186
Common Stock                                
Issued to Directors 10
 1
 
 6
 
 7
 
 7
 
 
 
 
 
 
 
 
Issued to Employees 18
 2
 
 
 
 2
 
 2
 
 
 
 
 
 
 
 
Net Income 
 
 
 
 2,404
 2,404
 
 2,404
 
 
 
 
 581
 581
 
 581
                                
June 30, 2019 24,715
 $2,472
 $58,920
 $(2) $128,278
 $189,668
 $289
 $189,957
September 30, 2019 24,715
 $2,472
 $59,202
 $(2) $128,859
 $190,531
 $289
 $190,820
                                
March 31, 2018 24,311
 $2,451
 $56,422
 $(184) $128,807
 $187,496
 $289
 $187,785
June 30, 2018 24,311
 $2,451
 $56,365
 $(61) $131,022
 $189,777
 $289
 $190,066
                                
Stock Options                                
Issued to Directors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Issued to Employees 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cancellation of Issuance to Former Director 
 
 (680) 
 
 (680) 
 (680) 
 
 
 
 
 
 
 
Restricted Stock Units                                
Issued to Directors 
 
 82
 
 
 82
 
 82
 
 
 75
 
 
 75
 
 75
Issued to Employees 
 
 385
 
 
 385
 
 385
 
 
 550
 
 
 550
 
 550
Common Stock                                
Issued to Directors 
 
 (15) 13
 
 (2) 
 (2) 
 
 159
 41
 
 200
 
 200
Issued to Employees 
 
 171
 110
 
 281
 
 281
 
 
 (2) 1
 
 (1) 
 (1)
Stock Exchange 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Income 
 
 
 
 2,215
 2,215
 
 2,215
 
 
 
 
 (1,609) (1,609) 
 (1,609)
                                
June 30, 2018 24,311
 $2,451
 $56,365
 $(61) $131,022
 $189,777
 $289
 $190,066
September 30, 2018 24,311
 $2,451
 $57,147
 $(19) $129,413
 $188,992
 $289
 $189,281

See notes to consolidated financial statements.

  
 3 




TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)
SIXNINE MONTHS ENDED JUNESEPTEMBER 30
 TRECORA RESOURCES STOCKHOLDERS     TRECORA RESOURCES STOCKHOLDERS    
 COMMON STOCK 
ADDITIONAL
PAID-IN
 TREASURY RETAINED   
NON-
CONTROLLING
 TOTAL COMMON STOCK 
ADDITIONAL
PAID-IN
 TREASURY RETAINED   
NON-
CONTROLLING
 TOTAL
 SHARES AMOUNT CAPITAL STOCK EARNINGS TOTAL INTEREST EQUITY SHARES AMOUNT CAPITAL STOCK EARNINGS TOTAL INTEREST EQUITY
 (thousands)
 (thousands of dollars) (thousands)
 (thousands of dollars)
January 1, 2019 24,626
 $2,463
 $58,294
 $(8) $124,123
 $184,872
 $289
 $185,161
 24,626
 $2,463
 $58,294
 $(8) $124,123
 $184,872
 $289
 $185,161
                                
Restricted Stock Units                                
Issued to Directors 
 
 168
 
 
 168
 
 168
 
 
 264
 
 
 264
 
 264
Issued to Employees 
 
 458
 
 
 458
 
 458
 
 
 644
 
 
 644
 
 644
Common Stock                                
Issued to Directors 10
 1
 
 6
 
 7
 
 7
 10
 1
 
 6
 
 7
 
 7
Issued to Employees 79
 8
 
 
 
 8
 
 8
 79
 8
 
 
 
 8
 
 8
Net Income 
 
 
 
 4,155
 4,155
 
 4,155
 
 
 
 
 4,736
 4,736
 
 4,736
                                
June 30, 2019 24,715
 $2,472
 $58,920
 $(2) $128,278
 $189,668
 $289
 $189,957
September 30, 2019 24,715
 $2,472
 $59,202
 $(2) $128,859
 $190,531
 $289
 $190,820
                                
January 1, 2018 24,311
 $2,451
 $56,012
 $(196) $126,455
 $184,722
 $289
 $185,011
 24,311
 $2,451
 $56,012
 $(196) $126,455
 $184,722
 $289
 $185,011
                                
Stock Options           

   

           

   

Issued to Directors 
 
 (10) 
 
 (10) 
 (10) 
 
 (10) 
 
 (10) 
 (10)
Issued to Employees 
 
 154
 
 
 154
 
 154
 
 
 154
 
 
 154
 
 154
Cancellation of Issuance to Former Director 
 
 (680) 
 
 (680) 
 (680) 
 
 (680) 
 
 (680) 
 (680)
Restricted Stock Units           
   
           

   

Issued to Directors 
 
 175
 
 
 175
 
 175
 
 
 250
 
 
 250
 
 250
Issued to Employees 
 
 734
 
 
 734
 
 734
 
 
 1,284
 
 
 1,284
 
 1,284
Common Stock                                
Issued to Directors 
 
 (78) 37
 
 (41) 
 (41) 
 
 82
 78
 
 160
 
 160
Issued to Employees 
 
 132
 154
 
 286
 
 286
 
 
 130
 155
 
 285
 
 285
Stock Exchange 
 
 (65) (65) 
 (130) 
 (130) 
 
 (66) (65) 
 (131) 
 (131)
Warrants 
 
 (9) 9
 
 
 
 
 
 
 (9) 9
 
 
 
 
Net Income 
 
 
 
 4,567
 4,567
 
 4,567
 
 
 
 
 2,958
 2,958
 
 2,958
                                
June 30, 2018 24,311
 $2,451
 $56,365
 $(61) $131,022
 $189,777
 $289
 $190,066
September 30, 2018 24,311
 $2,451
 $57,147
 $(19) $129,413
 $188,992
 $289
 $189,281

See notes to consolidated financial statements.



  
 4 





TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
 SIX MONTHS ENDED
JUNE 30,
 NINE MONTHS ENDED
SEPTEMBER 30,
 2019 2018 2019 2018
 (thousands of dollars) (thousands of dollars)
OPERATING ACTIVITIES        
Net Income $4,155
 $4,567
 $4,736
 $2,958
Adjustments to Reconcile Net Income    
To Net Cash Provided by Operating Activities:    
Loss from Discontinued Operations (1,120) (531)
Income from Continuing Operations $5,856
 $3,489
Adjustments to Reconcile Income from Continuing Operations To Net Cash Provided by Operating Activities:    
Depreciation and Amortization 7,880
 4,941
 10,863
 8,614
Amortization of Intangible Assets 931
 931
 1,396
 1,396
Stock-based Compensation 558
 372
 904
 1,002
Deferred Income Taxes 947
 1,073
 1,268
 1,116
Postretirement Obligation (18) (809) (28) (817)
Equity in Losses (Earnings) of AMAK 150
 (458)
Bad Debt Expense 
 128
 (19) 152
Amortization of Loan Fees 91
 161
 136
 216
Loss on Extinguishment of Debt 
 315
Changes in Operating Assets and Liabilities:        
Increase in Trade Receivables (3,393) (817)
Decrease (Increase) in Trade Receivables 1,634
 (4,160)
Increase in Insurance Receivables 
 (493) 
 (391)
Decrease in Taxes Receivable 
 4,293
 
 4,029
Decrease in Inventories 1,244
 1,448
 3,253
 622
Decrease (Increase) in Prepaid Expenses and Other Assets 16
 (901)
Increase in Prepaid Expenses and Other Assets 914
 (1,592)
Decrease in Accounts Payable and Accrued Liabilities (6,767) (4,742) (6,031) (2,977)
Decrease in Other Liabilities 54
 104
 267
 96
Net Cash Provided by Operating Activities - Continuing Operations 20,413
 11,110
Net Cash Used in Operating Activities - Discontinued Operations (164) 
Net Cash Provided by Operating Activities 5,848
 9,798
 20,249
 11,110
    
INVESTING ACTIVITIES        
Additions to Plant, Pipeline and Equipment (4,286) (15,434) (6,978) (19,090)
Proceeds from PEVM 30
 
 27
 
Advances to AMAK, net (26) (83)
Proceeds from AMAK Share Repurchase 440
 
Net Cash Used in Investing Activities - Continuing Operations (6,951) (19,090)
Net Cash Provided by (Used in) Investing Activities - Discontinued Operations 2,697
 (114)
Net Cash Used in Investing Activities (3,842) (15,517) (4,254) (19,204)
    
FINANCING ACTIVITIES        
Net Cash (Paid) Received Related to Stock-Based Compensation (228) 245
 (292) 441
Additions to Long-Term Debt 2,000
 16,000
 2,000
 18,177
Repayments of Long-Term Debt (6,188) (10,167) (15,281) (12,260)
Net Cash (Used in) Provided by Financing Activities (4,416) 6,078
    
NET (DECREASE) INCREASE IN CASH (2,410) 359
    
Net Cash (Used in) Provided by Financing Activities - Continuing Operations (13,573) 6,358
NET INCREASE (DECREASE) IN CASH 2,422
 (1,736)
CASH AT BEGINNING OF PERIOD 6,735
 3,028
 6,735
 3,028
    
CASH AT END OF PERIOD $4,325
 $3,387
 $9,157
 $1,292
    
Supplemental disclosure of cash flow information:    
Cash payments for interest $1,355
 $2,394
 $3,749
 $2,663
Cash payments for taxes, net of refunds $80
 $92
 $53
 $209
Supplemental disclosure of non-cash items:        
Capital expansion amortized to depreciation expense $244
 $210
 $426
 $573
Foreign taxes paid by AMAK $891
 $
 $891
 $
Stock exchange (Note 16) $
 $130
 $
 $131

See notes to consolidated financial statements.

  
 5 




TRECORA RESOURCES AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


1. GENERAL

Organization

Trecora Resources (the "Company") was incorporated in the State of Delaware in 1967. Our principal business activities are the manufacturing of various specialty hydrocarbons and specialty waxes and the provision of custom processing services.   Unless the context requires otherwise, references to "we," "us," "our," and the "Company" are intended to mean Trecora Resources and its subsidiaries.

This document includes the following abbreviations:
(1)TREC – Trecora Resources
(2)TOCCO – Texas Oil & Chemical Co. II, Inc. – Wholly owned subsidiary of TREC and parent of SHR and TC
(3)SHR – South Hampton Resources, Inc. – Specialty Petrochemicals segment and parent of GSPL
(4)GSPL – Gulf State Pipe Line Co, Inc. – Pipeline support for the Specialty Petrochemicals segment
(5)TC – Trecora Chemical, Inc. – Specialty Waxes segment
(6)AMAK – Al Masane Al Kobra Mining Company – MiningHeld-for-sale mining equity investment – 33% ownership
(7)PEVM – Pioche Ely Valley Mines, Inc. – Inactive mine – 55% ownership

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and, therefore, should be read in conjunction with the financial statements and related notes contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.

The unaudited condensed financial statements included in this document have been prepared on the same basis as the annual financial statements and in management's opinion reflect all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial position, results of operations and cash flows for the interim periods presented. We have made estimates and judgments affecting the amounts reported in this document. The actual results that we experience may differ materially from our estimates. In the opinion of management, the disclosures included in these financial statements are adequate to make the information presented not misleading.

Operating results for the sixnine months ended JuneSeptember 30, 2019 are not necessarily indicative of results for the year ending December 31, 2019.

We currently operate in two segments, Specialty Petrochemicals and Specialty Waxes. All revenue originates from sources in the United States, and all long-lived assets owned are located in the United States.

In addition, we own a 33% interest in AMAK, a Saudi Arabian closed joint stock company, which owns, operates and is developing mining assets in Saudi Arabia. We account for ourOur investment underis classified as held-for-sale and and the equity method of accounting.in earnings (losses) are recorded in discontinued operations. See Note 16.Notes 16 and 19.

Accounting Standards Adopted in 2019

In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases (Topic 842), as amended by ASU 2017-13, 2018-01, 2018-10, 2018-11, and 2019-01, in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under prior GAAP and disclosing key information about leasing arrangements. The new standard requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. The Company adopted ASC 842 in the first quarter of 2019 utilizing the modified retrospective transition approach. The Company has elected (1) the package of practical expedients,

  
 6 




expedients, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs for any existing leases as of the adoption date, and (2) the hindsight practical expedient when determining lease term and assessing impairment of right-of-use assets. In addition, the Company elected the practical expedients related to (1) certain classes of underlying asset to not separate non-lease components from lease components and (2) the short-term lease recognition exemption for all leases that qualify. The adoption of ASC 842 on January 1, 2019 resulted in the recognition of right-of-use assets of approximately $17.0 million and lease liabilities for operating leases of approximately $17.0 million on its Consolidated Balance Sheets, with no material impact to retained earnings or Consolidated Statements of Operations. See Note 8 for further information regarding the impact of the adoption of ASC 842 on the Company's consolidated financial statements.

7




2. RECENT ACCOUNTING PRONOUNCEMENTS

In January 2017, the FASB issued ASU No. 2017-4, Intangibles - Goodwill and Other (Topic 350). The amendments in ASU 2017-4 simplify the measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Instead, under these amendments, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value; however, the loss should not exceed the total amount of goodwill allocated to that reporting unit. The amendments are effective for public business entities for the first interim and annual reporting periods beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The amendments also eliminate the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The Company has goodwill from a prior business combination and performs an annual impairment test or more frequently if changes or circumstances occur that would more-likely-than-not reduce the fair value of the reporting unit below its carrying value. During the year ended December 31, 2018, the Company performed its impairment assessment and determined the fair value of the aggregated reporting units exceed the carrying value, such that the Company's goodwill was not considered impaired. AlthoughBased on the most recent assessment, the Company cannot anticipate future goodwill impairment assessments, based on the most recent assessment, it is unlikely that an impairment amount would need to be calculated and, therefore, theassessments. The Company does not anticipate a material impact from these amendments to the Company's financial position and results of operations. The current accounting policies and processes are not anticipated to change, except for the elimination of the Step 2 analysis.

In June 2018, the FASB issued ASU No. 2018-07, Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 simplifies the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The Company adopted this ASU on January 1, 2019 and it did not have a material effect on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) - Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is designed to improve the effectiveness of disclosures by removing, modifying and adding disclosures related to fair value measurements. ASU No. 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and the ASU allows for early adoption in any interim period after issuance of the update. The adoption of this ASU is not expected to have a significant impact on the Company’s consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326), to require the measurement of expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable forecasts and applies to all financial assets, including trade receivables. The main objective of this ASU is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. ASU No. 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and the ASU allows for early adoption as of the beginning of an interim or annual reporting period beginning after December 15, 2018. The Company is currently assessing the impact this ASU will have on its consolidated financial statements.


7




3. TRADE RECEIVABLES

Trade receivables, net, consisted of the following:
 June 30, 2019
 December 31, 2018
 September 30, 2019
 December 31, 2018
 (thousands of dollars) (thousands of dollars)
Trade receivables $30,958
 $27,564
 $25,930
 $27,564
Less allowance for doubtful accounts (440) (452) (433) (452)
Trade receivables, net $30,518
 $27,112
 $25,497
 $27,112

Trade receivables servesserve as collateral for our amended and restated credit agreement. See Note 10.

4. PREPAID EXPENSES AND OTHER ASSETS

Prepaid expenses and other assets consisted of the following:
  September 30, 2019
 December 31, 2018
  (thousands of dollars)
Prepaid license $1,411
 $2,419
Spare parts 1,816
 1,597
Other prepaid expenses and assets 499
 648
Total prepaid expenses and other assets $3,726
 $4,664

5. INVENTORIES

Inventories included the following:
  September 30, 2019
 December 31, 2018
  (thousands of dollars)
Raw material $3,278
 $4,742
Work in process 157
 173
Finished products 9,850
 11,624
Total inventory $13,285
 $16,539

Inventory serves as collateral for our amended and restated credit agreement. See Note 10.

Inventory included Specialty Petrochemicals products in transit valued at approximately $3.1 million and $4.1 million at September 30, 2019, and December 31, 2018, respectively.

6. PLANT, PIPELINE AND EQUIPMENT

Plant, pipeline and equipment consisted of the following:
  September 30, 2019
 December 31, 2018
  (thousands of dollars)
Platinum catalyst metal $1,580
 $1,612
Catalyst 4,387
 3,131
Land 5,428
 5,428
Plant, pipeline and equipment 259,435
 253,905
Construction in progress 4,442
 4,343
Total plant, pipeline and equipment $275,272
 $268,419
Less accumulated depreciation (84,927) (73,762)
Net plant, pipeline and equipment $190,345
 $194,657

  
 8 




4. PREPAID EXPENSES AND OTHER ASSETS

Prepaid expenses and other assets consisted of the following:
  June 30, 2019
 December 31, 2018
  (thousands of dollars)
Prepaid license $1,612
 $2,419
Spare parts 1,667
 1,597
Other prepaid expenses and assets 672
 648
Total prepaid expenses and other assets $3,951
 $4,664

5. INVENTORIES

Inventories included the following:
  June 30, 2019
 December 31, 2018
  (thousands of dollars)
Raw material $3,963
 $4,742
Work in process 244
 173
Finished products 11,088
 11,624
Total inventory $15,295
 $16,539

Inventory serves as collateral for our amended and restated credit agreement. See Note 10.

Inventory included Specialty Petrochemicals products in transit valued at approximately $3.2 million and $4.1 million at June 30, 2019, and December 31, 2018, respectively.

6. PLANT, PIPELINE AND EQUIPMENT

Plant, pipeline and equipment consisted of the following:
  June 30, 2019
 December 31, 2018
  (thousands of dollars)
Platinum catalyst metal $1,580
 $1,612
Catalyst 3,974
 3,131
Land 5,428
 5,428
Plant, pipeline and equipment 257,986
 253,905
Construction in progress 3,888
 4,343
Total plant, pipeline and equipment $272,856
 $268,419
Less accumulated depreciation (81,328) (73,762)
Net plant, pipeline and equipment $191,528
 $194,657

Plant, pipeline, and equipment serve as collateral for our amended and restated credit agreement. See Note 10.

Interest capitalized for construction was approximately $0.0 million and $0.4 million for the three months and $0.0 million and $0.7 million for the six months ended June 30, 2019 and 2018, respectively.

Labor capitalized for construction was approximately $0.0 millionnil and $0.9$0.1 million for the three months and $0.1 million and $2.1$2.2 million for the sixnine months ended JuneSeptember 30, 2019 and 2018, respectively.

Construction in progress during the first sixnine months of 2019 included sales rack and Advanced Reformer unit improvements and pipeline maintenance at SHR and equipment modifications at TC. Construction in progress during the first sixnine months of 2018 included equipment purchased for various equipment updates at the TC facility, the Advanced Reformer unit, tankage upgrades, and an addition to the rail spur at SHR.

9




Amortization relating to the catalyst, which is included in cost of sales, was approximately $0.2 million and $0.0 millionnil for the three months and $0.5$0.7 million and $0.0 millionnil for the sixnine months ended JuneSeptember 30, 2019 and 2018, respectively.

7. GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill and intangible assets were recorded in relation to the acquisition of TC on October 1, 2014.

Goodwill was $21.8 million and $21.8 million as of September 30, 2019 and December 31, 2018, respectively.

The following tables summarize the gross carrying amounts and accumulated amortization of intangible assets by major class:
 June 30, 2019 September 30, 2019
 Gross 
Accumulated
Amortization
 Net Gross 
Accumulated
Amortization
 Net
Intangible assets subject to amortization (Definite-lived) (thousands of dollars) (thousands of dollars)
Customer relationships $16,852
 $(5,336) $11,516
 $16,852
 $(5,617) $11,235
Non-compete agreements 94
 (90) 4
 94
 (94) 
Licenses and permits 1,471
 (549) 922
 1,471
 (575) 896
Developed technology 6,131
 (2,912) 3,219
 6,131
 (3,066) 3,065
 24,548
 (8,887) 15,661
 24,548
 (9,352) 15,196
Intangible assets not subject to amortization (Indefinite-lived)            
Emissions allowance 197
 
 197
 197
 
 197
Trade name 2,158
 
 2,158
 2,158
 
 2,158
Total $26,903
 $(8,887) $18,016
 $26,903
 $(9,352) $17,551
  December 31, 2018
  Gross 
Accumulated
Amortization
 Net
Intangible assets subject to amortization (Definite-lived) (thousands of dollars)
Customer relationships $16,852
 $(4,775) $12,077
Non-compete agreements 94
 (80) 14
Licenses and permits 1,471
 (495) 976
Developed technology 6,131
 (2,606) 3,525
  24,548
 (7,956) 16,592
Intangible assets not subject to amortization (Indefinite-lived)      
Emissions allowance 197
 
 197
Trade name 2,158
 
 2,158
Total $26,903
 $(7,956) $18,947

Amortization expense for intangible assets included in cost of sales for the three months ended JuneSeptember 30, 2019 and 2018, was approximately $0.5 million and $0.5 million, respectively, and for the sixnine months ended JuneSeptember 30, 2019 and 2018, was approximately $0.9$1.4 million and $0.9$1.4 million, respectively.

  
 109 





Based on identified intangible assets that are subject to amortization as of JuneSeptember 30, 2019, we expect future amortization expenses for each period to be as follows:
 Total
 Remainder of 2019
 2020
 2021
 2022
 2023
 2024
 Thereafter
 Total
 Remainder of 2019
 2020
 2021
 2022
 2023
 2024
 Thereafter
 (thousands of dollars) (thousands of dollars)
Customer relationships $11,516
 $562
 $1,123
 $1,123
 1,123
 1,123
 1,123
 $5,339
 $11,235
 $281
 $1,123
 $1,123
 1,123
 1,123
 1,123
 $5,339
Non-compete agreements 4
 4
 
 
 
 
 
 
Licenses and permits 922
 53
 106
 101
 86
 86
 86
 404
 896
 26
 106
 101
 86
 86
 86
 405
Developed technology 3,219
 307
 613
 613
 613
 613
 460
 
 3,065
 153
 613
 613
 613
 613
 460
 
Total future amortization expense $15,661
 $926
 $1,842
 $1,837
 $1,822
 $1,822
 $1,669
 $5,743
 $15,196
 $460
 $1,842
 $1,837
 $1,822
 $1,822
 $1,669
 $5,744

8. LEASES
The Company leases certain rail cars, rail equipment, office space and office equipment. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right of useright-of-use assets at the inception of the lease and accounts for these options when they are reasonably certain of being exercised.

Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets. Lease expense for these leases is recognized on a straight-line basis over the lease term.
The components of lease expense were as follows:
($ in thousands)Classification in the Condensed Consolidated Statements of IncomeThree Months Ended
June 30, 2019
 Six Months Ended
June 30, 2019
Classification in the Condensed Consolidated Statements of IncomeThree Months Ended
September 30, 2019
 Nine Months Ended
September 30, 2019
Operating lease cost (a)Cost of sales, exclusive of depreciation and amortization$1,152
 $2,291
Cost of sales, exclusive of depreciation and amortization$1,114
 $3,369
Operating lease cost (a)Selling, general and administrative38
 72
Selling, general and administrative34
 103
Total operating lease cost $1,190
 $2,363
 $1,148
 $3,472
        
Finance lease cost:        
Amortization of right-of-use assetsDepreciation$
 
Depreciation$
 
Interest on lease liabilitiesInterest Expense
 
Interest Expense
 
Total finance lease cost $
 $
 $
 $
        
Total lease cost $1,190
 $2,363
 $1,148
 $3,472
        
(a) Short-term lease costs were approximately $64 thousand during the period.(a) Short-term lease costs were approximately $64 thousand during the period.  (a) Short-term lease costs were approximately $64 thousand during the period.  

  
 1110 




The Company had no variable lease expense, as defined by ASC 842, during the period.
($ in thousands)Classification on the Condensed Consolidated Balance SheetsJune 30, 2019Classification on the Condensed Consolidated Balance SheetsSeptember 30, 2019
Assets:    
OperatingOperating lease assets$15,197
Operating lease assets$14,364
FinanceProperty, plant, and equipment
Property, plant, and equipment
Total leased assets $15,197
 $14,364
    
Liabilities:    
Current    
OperatingCurrent portion of operating lease liabilities$3,412
Current portion of operating lease liabilities$3,247
FinanceShort-term debt and current portion of long-term debt
Short-term debt and current portion of long-term debt
Noncurrent    
OperatingOperating lease liabilities11,785
Operating lease liabilities11,117
FinanceLong-term debt
Long-term debt
Total lease liabilities $15,197
 $14,364
($ in thousands)Three Months Ended
June 30, 2019
 Six Months Ended
June 30, 2019
Three Months Ended
September 30, 2019
 Nine Months Ended
September 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:      
Operating cash flows used for operating leases$1,127
 $2,260
$1,127
 $2,260
Operating cash flows used for finance leases
 

 
Financing cash flows used for finance leases
 

 
Right-of-use assets obtained in exchange for lease obligations:      
Operating leases$25
 $138
$25
 $138
Finance leases
 

 
 JuneSeptember 30, 2019
Weighted-average remaining lease term (in years): 
Operating leases4.8
Finance leases0.0
Weighted-average discount rate: 
Operating leases4.5%
Finance leases%
Nearly all of the Company’s lease contracts do not provide a readily determinable implicit rate. For these contracts, the Company’s estimated incremental borrowing rate is based on information available at the inception of the lease.
As of JuneSeptember 30, 2019, maturities of lease liabilities were as follows:
($ in thousands)Operating LeasesFinance LeasesOperating LeasesFinance Leases
2020$4,010
$
$3,811
$
20213,576

3,559

20223,480

3,391

20232,806

2,571

20241,460

1,243

Thereafter1,549

1,329

Total lease payments$16,881
$
$15,904
$
Less: Interest1,684

1,540

Total lease obligations$15,197
$
$14,364
$

  
 1211 




Disclosures related to periods prior to adoption of ASU 2016-02
The Company adopted ASU 2016-02 using a modified retrospective transition approach on January 1, 2019 as noted in Note 1. As required, the following disclosure is provided for periods prior to adoption. Minimum lease commitments as of December 31, 2018 that have initial or remaining lease terms in excess of one year are as follows:
($ in thousands)Operating Leases
2019$3,670
20203,583
20213,418
20223,107
20232,288
Beyond 20232,065

9. ACCRUED LIABILITIES

Accrued liabilities consisted of the following:
 June 30, 2019
 December 31, 2018
 September 30, 2019
 December 31, 2018
 (thousands of dollars) (thousands of dollars)
Accrued state taxes 262
 210
 249
 210
Accrued property taxes 1,720
 
 2,572
 
Accrued payroll 981
 936
 812
 936
Accrued interest 32
 31
 32
 31
Accrued officer compensation 650
 
 1,251
 
Accrued restructuring & severance 37
 1,221
 37
 1,221
Accrued foreign taxes 
 802
 
 802
Other 1,733
 2,239
 2,317
 2,239
Total $5,415
 $5,439
 $7,270
 $5,439

10. LIABILITIES AND LONG-TERM DEBT

Senior Secured Credit Facilities

As of JuneSeptember 30, 2019, we had $16.0$8.0 million in borrowings outstanding under the revolving credit facility (the "Revolving Facility") of our amended and restated credit agreement (as amended to the date hereof, the "ARC Agreement") and approximately $83.1$82.0 million in borrowings outstanding under the term loan facility of the ARC Agreement (the "Term Loan Facility" and, together with the Revolving Facility, the "Credit Facilities"). In addition, we had approximately $42$46 million of available borrowingsavailability under our Revolving Facility at JuneSeptember 30, 2019. TOCCO’s ability to make additional borrowings under the Revolving Facility at JuneSeptember 30, 2019 was limited by, and in the future may be limited by our obligation to maintain compliance with the covenants contained in the ARC Agreement (including maintenance of a maximum Consolidated Leverage Ratio and minimum Consolidated Fixed Charge Coverage Ratio (each as defined in the ARC Agreement)).

On March 29, 2019, TOCCO, as borrower, and SHR, GSPL and TC, as guarantors, entered into a Sixth Amendment (“Sixth Amendment”) to the ARC Agreement. Pursuant to the Sixth Amendment, certain amendments were made to the terms of the ARC Agreement, including increasing the maximum Consolidated Leverage Ratio that must be maintained by TOCCO to 4.75 to 1.00 for the four fiscal quarters ended March 31, 2019, 4.50 to 1.00 for the four fiscal quarters ended June 30, 2019 and 4.00 to 1.00 for the four fiscal quarters ended September 30, 2019. For the four fiscal quarters ended December 31, 2019 and each fiscal quarter thereafter, TOCCO must maintain a Consolidated Leverage Ratio of 3.50 to 1.00 (subject to temporary increase following certain acquisitions).

The maturity date for the ARC Agreement is July 31, 2023. As of JuneSeptember 30, 2019, the effective interest rate for the Credit Facilities was 4.87%4.59%. The ARC Agreement contains a number of customary affirmative and negative covenants and we were in compliance with those covenants as of JuneSeptember 30, 2019.


  
 1312 




For a summary of additional terms of the Credit Facilities, see Note 12, “Long-Term Debt and Long-Term Obligations” to the consolidated financial statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2018.

Debt Issuance Costs

Debt issuance costs of approximately $0.9 million were incurred in connection with the fourth amendment to the ARC Agreement. Unamortized debt issuance costs of approximately $0.7 million and $0.8 million for the periods ended JuneSeptember 30, 2019 and December 31, 2018, have been netted against outstanding loan balances.

Long-term debt and long-term obligations are summarized as follows:
June 30, 2019 December 31, 2018September 30, 2019 December 31, 2018
(thousands of dollars)(thousands of dollars)
Revolving Facility16,000
 18,000
8,000
 18,000
Term Loan Facility83,125
 85,312
82,031
 85,312
Loan fees(740) (830)(694) (830)
Total long-term debt98,385
 102,482
89,337
 102,482
      
Less current portion including loan fees4,194
 4,194
4,194
 4,194
      
Total long-term debt, less current portion including loan fees94,191
 98,288
85,143
 98,288

Subsequent to JuneSeptember 30, 2019, we made an optional principal payment of $4.0$5.0 million against the Revolving Facility, reducing the outstanding amount from $16.0$8.0 million to $12.0$3.0 million.

11. STOCK-BASED COMPENSATION

The Stock Option Plan for Key Employees, as well as, the Non-Employee Director Stock Option Plan (hereinafter collectively referred to as the “Stock Option Plans”), were approved by the Company’s stockholders in July 2008. The Stock Option Plans allot for the issuance of up to 1,000,000 shares.

The Trecora Resources Stock and Incentive Plan (the “Plan”) was approved by the Company’s stockholders in June 2012. As amended, the Plan allots for the issuance of up to 2.5 million shares in the form of stock options or restricted stock unit awards.

Share-basedStock-based compensation expense of approximately $0.3 million and $(0.2)$0.6 million was recognized during the three months and $0.6$0.9 million and $0.4$1.0 million for the sixnine months ended JuneSeptember 30, 2019 and 2018, respectively.

Stock Options and Warrant Awards

Stock options and warrants granted under the provisions of the Stock Option Plans permit the purchase of our common stock at exercise prices equal to the closing price of Company common stock on the date the options were granted. The options have terms of 10 years and generally vest ratably over terms of 4 to 5 years. There were no stock options or warrant awards issued during the three or sixnine months ended JuneSeptember 30, 2019 or 2018.

A summary of the status of the Company’s stock option and warrant awards is as follows:

  
 1413 




A summary of the status of the Company’s stock option and warrant awards is as follows:
Stock Options and Warrants
 
Weighted
Average
Exercise
Price
Per Share

 
Weighted
Average
Remaining
Contractual
Life
 
Intrinsic
Value
(in thousands)

Stock Options and Warrants
 
Weighted
Average
Exercise
Price
Per Share

 
Weighted
Average
Remaining
Contractual
Life
 
Intrinsic
Value
(in thousands)

Outstanding at January 1, 2019745,830
 10.33  745,830
 10.33  
Granted
 
  
 
  
Exercised(85,000) 7.71  (85,000) 7.71  
Forfeited(108,830) 8.80
  (173,830) 10.10
  
Outstanding at June 30, 2019552,000
 11.04 3.8 $
Outstanding at September 30, 2019487,000
 10.87 3.8 $
Expected to vest
   $

   $
Exercisable at June 30, 2019552,000
 11.04 3.8 $
Exercisable at September 30, 2019487,000
 10.87 3.8 $

The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At JuneSeptember 30, 2019, options to purchase approximately 0.1 million shares of common stock were in-the-money.

Since no options were granted, the weighted average grant-date fair value per share of options granted during the three months ended JuneSeptember 30, 2019 and 2018, respectively, was $0. During the sixnine months ended JuneSeptember 30, 2019 and 2018, the aggregate intrinsic value of options and warrants exercised was approximately $0.1 million and $0.6 million, respectively, determined as of the date of option exercise.

The Company received no cash from the exercise of options during the sixnine months ended JuneSeptember 30, 2019 and 2018. Of the 85,000 stock options exercised, the Company only issued approximately 11,000 shares due to cashless transactions. The tax benefit realized from the exercise was insignificant.

The Company has no non-vested options as of JuneSeptember 30, 2019.
Restricted Stock Unit Awards
Generally, restricted stock unit awards are granted annually to officers and directors of the Company under the provisions of the Plan. Restricted stock units are also granted ad hoc to attract or retain key personnel, and the terms and conditions under which these restricted stock units vest vary by award. The fair market value of restricted stock units granted is equal to the Company’s closing stock price on the date of grant. Restricted stock units granted generally vest ratably over periods ranging from 2.5 to 5 years. Certain awards also include vesting provisions based on performance metrics. Upon vesting, the restricted stock units are settled by issuing one share of Company common stock per unit.

A summary of the status of the Company's restricted stock units activity is as follows:
Shares of Restricted
Stock Units

 Weighted Average Grant Date Price per Share
Shares of Restricted
Stock Units

 Weighted Average Grant Date Price per Share
Outstanding at January 1, 2019405,675
 11.27405,675
 11.27
Granted190,615
 9.22190,615
 9.22
Forfeited(64,463) 12.13(123,434) 10.82
Vested(136,568) 11.86(136,568) 11.86
Outstanding at June 30, 2019395,259
 9.77
Outstanding at September 30, 2019336,288
 9.83
Expected to vest395,259
 336,288
 

12. INCOME TAXES

We file an income tax return in the U.S. federal jurisdiction and a margin tax return in Texas. We received notification from the Internal Revenue Service ("IRS") in November 2016 that the December 31, 2014, tax return was selected for audit. In April 2017, the audit was expanded to include the year ended December 31, 2015, to review the refund claim related to research and development activities. We received notification from the IRS in March 2018 that the audit was complete. We

  
 1514 




research and development activities. We received notification from the IRS in March 2018 that the audit was complete. We also received notification that Texas will audit our R&D credit calculations for 2014 and 2015. We were notified by Texas that the audit has been temporarily suspended as the Comptroller's office reviews its audit process regarding R&D credits. We do not expect any changes related to the Texas audit. Tax returns for various jurisdictions remain open for examination for the years 2014 through 2018. As of JuneSeptember 30, 2019 and December 31, 2018, respectively, we recognized no adjustment for uncertain tax positions or related interest and penalties.

The effective tax rate varies from the federal statutory rate of 21%, primarily as a result of state tax expense, stock based compensation and a research and development credit for the three and sixnine months ended JuneSeptember 30, 2019 and 2018. We continue to maintain a valuation allowance against certain deferred tax assets, specifically for mining claims for PEVM, where realization is not certain.

13. NET INCOME PER COMMON SHARE ATTRIBUTABLE TO TRECORA RESOURCES

The following table (in thousands, except per share amounts) setstables set forth the computation of basic and diluted net income (loss) per share attributable to Trecora Resources for the three and nine months ended JuneSeptember 30, 2019 and 2018, respectively.

  Three Months Ended
June 30, 2019
 Three Months Ended
June 30, 2018
  Income
 Shares
 
Per Share
Amount

 Income
 Shares
 
Per Share
Amount

Basic Net Income per Share:            
Net Income Attributable to Trecora Resources $2,404
 24,696
 $0.10
 $2,215
 24,370
 $0.09
Unvested restricted stock units   395
     349
  
Dilutive stock options outstanding   
     295
  
Diluted Net Income per Share:            
Net Income Attributable to Trecora Resources $2,404
 25,091
 $0.10
 $2,215
 25,014
 $0.09
Net Income per Common Share - Continuing Operations
  Six Months Ended
June 30, 2019
 Six Months Ended
June 30, 2018
  Income
 Shares
 
Per Share
Amount

 Income
 Shares
 
Per Share
Amount

Basic Net Income per Share:            
Net Income Attributable to Trecora Resources $4,155
 24,675
 $0.17
 $4,567
 24,354
 $0.19
Unvested restricted stock units   414
     376
  
Dilutive stock options outstanding   
     389
  
Diluted Net Income per Share:            
Net Income Attributable to Trecora Resources $4,155
 25,089
 $0.17
 $4,567
 25,119
 $0.18
  Three Months Ended
September 30, 2019
 Three Months Ended
September 30, 2018
  Income (Loss)
 Shares
 
Per Share
Amount

 Income (Loss)
 Shares
 
Per Share
Amount

  (in thousands, except per share amounts)
Basic:            
Net income (loss) from continuing operations $1,583
 24,717
 $0.06
 $(716) 24,483
 $(0.03)
Unvested restricted stock units   336
     398
  
Dilutive stock options outstanding   
     294
  
Diluted:            
Net income (loss) from continuing operations $1,583
 25,053
 $0.06
 $(716) 25,175
 $(0.03)
  Nine Months Ended
September 30, 2019
 Nine Months Ended
September 30, 2018
  Income
 Shares
 
Per Share
Amount

 Income
 Shares
 
Per Share
Amount

  (in thousands, except per share amounts)
Basic:            
Net income (loss) from continuing operations $5,856
 24,689
 $0.24
 $3,489
 24,397
 $0.14
Unvested restricted stock units   388
     383
  
Dilutive stock options outstanding   
     358
  
Diluted:            
Net income (loss) from continuing operations $5,856
 25,077
 $0.23
 $3,489
 25,138
 $0.14


15




Net Income Common Share - Discontinued Operations
  Three Months Ended
September 30, 2019
 Three Months Ended
September 30, 2018
  Income (Loss)
 Shares
 
Per Share
Amount

 Income (Loss)
 Shares
 
Per Share
Amount

  (in thousands, except per share amounts)
Basic:            
Net income (loss) from discontinued operations, net of tax $(1,002) 24,717
 $(0.04) $(893) 24,483
 $(0.04)
Unvested restricted stock units   336
     398
  
Dilutive stock options outstanding   
     294
  
Diluted:            
Net income (loss) from discontinued operations, net of tax $(1,002) 25,053
 $(0.04) $(893) 25,175
 $(0.04)
  Nine Months Ended
September 30, 2019
 Nine Months Ended
September 30, 2018
  Income (Loss)
 Shares
 
Per Share
Amount

 Income (Loss)
 Shares
 
Per Share
Amount

  (in thousands, except per share amounts)
Basic:            
Net income (loss) from discontinued operations, net of tax $(1,120) 24,689
 $(0.05) $(531) 24,397
 $(0.02)
Unvested restricted stock units   388
     383
  
Dilutive stock options outstanding   
     358
  
Diluted:            
Net income (loss) from discontinued operations, net of tax $(1,120) 25,077
 $(0.04) $(531) 25,138
 $(0.02)

Net Income per Common Share
  Three Months Ended
September 30, 2019
 Three Months Ended
September 30, 2018
  Income (Loss)
 Shares
 
Per Share
Amount

 Income (Loss)
 Shares
 
Per Share
Amount

  (in thousands, except per share amounts)
Basic:            
Net income (loss) $581
 24,717
 $0.02
 $(1,609) 24,483
 $(0.07)
Unvested restricted stock units   336
     398
  
Dilutive stock options outstanding   
     294
  
Diluted:            
Net income (loss) $581
 25,053
 $0.02
 $(1,609) 25,175
 $(0.07)

16




  Nine Months Ended
September 30, 2019
 Nine Months Ended
September 30, 2018
  Income
 Shares
 
Per Share
Amount

 Income
 Shares
 
Per Share
Amount

  (in thousands, except per share amounts)
Basic:            
Net income (loss) $4,736
 24,689
 $0.19
 $2,958
 24,397
 $0.12
Unvested restricted stock units   388
     383
  
Dilutive stock options outstanding   
     358
  
Diluted:            
Net income (loss) $4,736
 25,077
 $0.19
 $2,958
 25,138
 $0.12

At JuneSeptember 30, 2019 and 2018, 552,000487,000 and 924,860873,708 shares of common stock, respectively, were issuable upon the exercise of options and warrants.

14. SEGMENT INFORMATION

We operate through business segments according to the nature and economic characteristics of our products as well as the manner in which the information is used internally by our key decision maker, who is our Chief Executive Officer. Segment data may include rounding differences.

Our Specialty Petrochemicals segment includes SHR and GSPL. Our Specialty Waxes segment is TC. We also separately identify our corporate overhead which includes financing and administrative activities such as legal, accounting, consulting, investor relations, officer and director compensation, corporate insurance, and other administrative costs.

 Three Months Ended September 30, 2019
 Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
 (in thousands)
Product sales$53,277
 $5,834
 $
 $
 $59,111
Processing fees1,208
 2,396
 
 
 3,604
Total revenues54,485
 8,230
 
 
 62,715
Operating profit (loss) before depreciation and amortization10,414
 (260) (2,670) 
 7,484
Operating profit (loss)7,449
 (1,808) (2,683) 
 2,958
Profit (loss) from continuing operations before taxes6,583
 (2,071) (2,691) 
 1,821
Depreciation and amortization1,900
 1,548
 14
 
 3,462
Capital expenditures2,163
 361
 
 
 2,524

  
 1617 




Three Months Ended June 30, 2019Three Months Ended September 30, 2018
Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
(in thousands)(in thousands)
Product sales$58,584
 $6,745
 $
 $
 $65,329
$61,675
 $6,938
 $
 
 $68,613
Processing fees1,527
 2,515
 
 
 4,042
2,056
 2,799
 
 (52) 4,803
Total revenues60,111
 9,260
 
 
 69,371
63,731
 9,737
 
 (52) 73,416
Operating profit (loss) before depreciation and amortization10,028
 766
 (2,182) 
 8,612
6,167
 415
 (2,252) 
 4,330
Operating profit (loss)7,104
 (633) (2,195) 
 4,276
3,516
 (936) (2,270) 
 310
Profit (loss) before taxes6,375
 (1,013) (2,294) 
 3,068
Profit (loss) from continuing operations before taxes2,561
 (1,239) (2,274) 
 (952)
Depreciation and amortization2,925
 1,399
 12
 
 4,336
2,651
 1,351
 16
 
 4,018
Capital expenditures1,461
 426
 
 
 1,887
2,562
 1,094
 
 
 3,656
Three Months Ended June 30, 2018Nine Months Ended September 30, 2019
Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
(in thousands)(in thousands)
Product sales$56,135
 $7,434
 $
 
 $63,569
$167,351
 $18,582
 $
 $
 $185,933
Processing fees1,685
 2,852
 
 
 4,537
4,117
 7,191
 
 
 11,308
Total revenues57,820
 10,286
 
 
 68,106
171,468
 25,773
 
 
 197,241
Operating profit (loss) before depreciation and amortization6,095
 1,164
 (834) 
 6,425
31,849
 (343) (7,158) 
 24,348
Operating profit (loss)4,440
 (201) (842) 
 3,397
22,885
 (4,638) (7,203) 
 11,044
Profit (loss) before taxes3,859
 (506) (542) 
 2,811
Profit (loss) from continuing operations before taxes20,093
 (5,623) (7,202) 
 7,268
Depreciation and amortization1,655
 1,365
 8
 
 3,028
7,899
 4,295
 46
 
 12,240
Capital expenditures3,529
 877
 
 
 4,406
5,002
 1,296
 
 
 6,298
Six Months Ended June 30, 2019Nine Months Ended September 30, 2018
Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
(in thousands)(in thousands)
Product sales$114,074
 $12,748
 $
 $
 $126,822
$178,094
 $20,755
 $
 32
 $198,881
Processing fees2,910
 4,794
 
 
 7,704
5,769
 8,863
 
 (250) 14,382
Total revenues116,984
 17,542
 
 
 134,526
183,863
 29,618
 
 (218) 213,263
Operating profit (loss) before depreciation and amortization21,435
 (83) (4,487) 
 16,865
20,655
 1,969
 (5,234) 
 17,390
Operating profit (loss)15,437
 (2,830) (4,521) 
 8,086
14,635
 (2,051) (5,268) 
 7,316
Profit (loss) before taxes13,510
 (3,552) (4,661) 
 5,297
Profit (loss) from continuing operations before taxes12,474
 (2,926) (5,205) 
 4,343
Depreciation and amortization5,999
 2,747
 32
 
 8,778
6,020
 4,020
 32
 
 10,072
Capital expenditures2,839
 935
 
 
 3,774
16,374
 2,716
 
 
 19,090
 Six Months Ended June 30, 2018
 Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
 (in thousands)
Product sales$116,420
 $13,817
 $
 31
 $130,268
Processing fees3,713
 6,064
 
 (198) 9,579
Total revenues120,133
 19,881
 
 (167) 139,847
Operating profit (loss) before depreciation and amortization14,488
 1,554
 (2,982) 
 13,060
Operating profit (loss)11,119
 (1,115) (2,998) 
 7,006
Profit (loss) before taxes9,913
 (1,687) (2,473) 
 5,753
Depreciation and amortization3,369
 2,669
 16
 
 6,054
Capital expenditures13,812
 1,622
 
 
 15,434

 June 30, 2019
 Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
 (in thousands)
Trade receivables, product sales$23,465
 $4,097
 $
 $
 $27,562
Trade receivables, processing fees1,042
 1,914
 
 
 2,956
Goodwill and intangible assets, net
 39,814
 
 
 39,814
Total assets299,103
 114,409
 91,247
 (166,126) 338,633
18




 September 30, 2019
 Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
 (in thousands)
Trade receivables, product sales$19,129
 $4,081
 $
 $
 $23,210
Trade receivables, processing fees517
 1,770
 
 
 2,287
Goodwill and intangible assets, net
 39,349
 
 
 39,349
Total assets293,098
 113,007
 90,174
 (165,722) 330,557
 December 31, 2018
 Specialty Petrochemicals
 Specialty Waxes
 Corporate
 Eliminations
 Consolidated
 (in thousands)
Trade receivables, product sales$21,915
 $3,173
 $
 $
 $25,088
Trade receivables, processing fees633
 1,391
 
 
 2,024
Goodwill and intangible assets, net
 40,745
 
 
 40,745
Total assets284,367
 115,366
 91,474
 (161,239) 329,968

15. POST-RETIREMENT OBLIGATIONS

We currently have post-retirement obligations with two former executives. As of JuneSeptember 30, 2019 and December 31, 2018, approximately $0.4$0.3 million and $0.4 million, respectively, remained outstanding and was included in post-retirement obligations.

For additional information, see Note 22, “Post–Retirement Obligations” to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2018.

16. INVESTMENT IN AMAK (Held-for-Sale)

As of JuneSeptember 30, 2019 and December 31, 2018, the Company had a non-controlling equity interest of 33.3% and 33.4% in AMAK of approximately $37.3$34.1 million and $38.7 million, respectively. This investment is accounted for under the equity method. There were no events or changes in circumstances that may have an adverse effect on the fair value of our investment in AMAK at JuneSeptember 30, 2019.

The Company committed to a plan to sell our investment in AMAK during the third quarter of 2019. Management engaged in an active program to market the investment which resulted in an agreement with certain AMAK shareholders in September 2019, which became effective subsequent to September 30, 2019. See discussion of the Share Sale and Purchase Agreement in Note 19.

As all the required criteria for held-for-sale classification was met at September 30, 2019, the investment in AMAK is classified as held-for-sale in the Consolidated Balance Sheets and reflected as discontinued operations in the Consolidated Statements of Operations for all periods presented. The assets held-for-sale are disclosed by the Company in the Corporate segment. The Company expects to have no continuing involvement with the discontinued operations after the closing date.  The gain (loss) from discontinued operations, net of tax, include our portion of the equity in earnings (losses) in AMAK as well as other administrative expenses incurred in Saudi Arabia and transaction costs.

AMAK's financial statements were prepared in the functional currency of AMAK which is the Saudi Riyal ("SR"). In June 1986 the SR was officially pegged to the U. S. Dollar ("USD") at a fixed exchange rate of 1 USD to 3.75 SR.


19




The summarized results of operation and financial position for AMAK are as follows:

Results of Operations
  Three Months Ended September 30, Nine Months Ended September 30,
  2019
 2018
 2019
 2018
  (thousands of dollars) (thousands of dollars)
Sales $19,643
 $19,877
 $60,873
 $53,458
Cost of sales 19,072
 20,350
 55,804
 49,411
Gross profit (loss) 571
 (473) 5,069
 4,047
Selling, general, and administrative 3,557
 2,736
 9,102
 7,151
Operating loss (2,986) (3,209) (4,033) (3,104)
Other income 43
 35
 396
 70
Finance and interest expense (456) (416) (1,349) (1,201)
Loss before Zakat and income taxes (3,399) (3,590) (4,986) (4,235)
Zakat and income taxes 444
 800
 1,332
 800
Net Loss $(3,843) $(4,390) $(6,318) $(5,035)

Financial Position
  September 30,
 December 31,
  2019
 2018
  (thousands of dollars)
Current assets $41,030
 $44,093
Noncurrent assets 191,043
 212,291
Total assets $232,073
 $256,384
     
Current liabilities $22,107
 $17,160
Long term liabilities 74,371
 77,366
Stockholders' equity 135,595
 161,858
  $232,073
 $256,384

Changes in Ownership

In the second quarter of 2019, certain shareholders of AMAK transferred a portion of their shares to the CEO of AMAK as a one-time retention and performance bonus. The Company transferred 100,000 shares and the transaction reduced our ownership percentage from 33.4% to 33.3%.


17




In first quarter 2018, we completed an exchange of shares with certain stockholders whereby such stockholders traded 65,000 common shares of TREC in exchange for 24,489 shares of our AMAK stock. The 65,000 shares were accounted for as treasury stock. This transaction reduced our ownership percentage from 33.44% to 33.41%.

AMAK's financial statements were prepared in the functional currency of AMAK which is the Saudi Riyal ("SR"). In June 1986 the SR was officially pegged to the U. S. Dollar ("USD") at a fixed exchange rate of 1 USD to 3.75 SR.

The summarized results of operation and financial position for AMAK are as follows:

Results of Operations
  Three Months Ended June 30, Six Months Ended June 30,
  2019
 2018
 2019
 2018
  (thousands of dollars) (thousands of dollars)
Sales $20,566
 $19,494
 $41,230
 $33,581
Cost of sales 18,162
 16,555
 36,732
 29,061
Gross profit 2,404
 2,939
 4,498
 4,520
Selling, general, and administrative 2,807
 2,892
 5,545
 4,415
Operating (loss) income (403) 47
 (1,047) 105
Other (expense) income (75) 15
 353
 34
Finance and interest expense (448) (388) (893) (785)
Loss before Zakat and income taxes (926) (326) (1,587) (646)
Zakat and income taxes 366
 
 888
 
Net Loss $(1,292) $(326) $(2,475) $(646)

Financial Position
  June 30,
 December 31,
  2019
 2018
  (thousands of dollars)
Current assets $35,658
 $44,093
Noncurrent assets 197,093
 212,291
Total assets $232,751
 $256,384
     
Current liabilities $19,201
 $17,160
Long term liabilities 74,111
 77,366
Stockholders' equity 139,439
 161,858
  $232,751
 $256,384

The equity in the (losses) earnings of AMAK reflected on the consolidated statements of income for the three and six months ended June 30, 2019, and 2018, is comprised of the following:

18




  Three Months Ended
June 30,
 Six Months Ended
June 30,
  2019
 2018
 2019
 2018
  (thousands of dollars) (thousands of dollars)
AMAK Net Loss $(1,292) $(326) $(2,475) $(646)
Percentage of Ownership 33.29% 33.41% 33.29% 33.41%
         
Company's share of loss reported by AMAK $(429) $(109) $(824) $(216)
Amortization of difference between Company's investment in AMAK and Company's share of net assets of AMAK 337
 337
 674
 674
Equity in (losses) earnings of AMAK $(91) $228
 $(150) $458

In connection with the 2018 AMAK share repurchase program, we received net proceeds of approximately $0.4 million during the three months ended March 31, 2019. AMAK completed the share repurchase program in 2019, at which point all shares repurchased from AMAK stockholders were registered as treasury shares. Upon completion of the share repurchase program, the Company's ownership percentage in AMAK did not change from 33.4%.


20




The equity in the (losses) earnings of AMAK included in loss from discontinued operations, net of tax, on the consolidated statements of operations for the three and nine months ended September 30, 2019, and 2018, is comprised of the following:
  Three Months Ended
September 30,
 Nine Months Ended
September 30,
  2019
 2018
 2019
 2018
  (thousands of dollars) (thousands of dollars)
AMAK Net Loss $(3,843) $(4,390) $(6,318) $(5,036)
Percentage of Ownership 33.29% 33.41% 33.29% 33.41%
         
Company's share of loss reported by AMAK $(1,279) $(1,467) $(2,103) $(1,682)
Amortization of difference between Company's investment in AMAK and Company's share of net assets of AMAK 337
 337
 1,010
 1,010
Equity in (losses) earnings of AMAK $(942) $(1,130) $(1,093) $(672)

For additional information, see Note 10, “Investment"Investment in Al Masane Al Kobra Mining Company ("AMAK")" to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2018.

At June 30, 2019, and December 31, 2018, we had a receivable from AMAK of approximately $0.1 million and $0.1 million, respectively, relating to unreimbursed travel and Board expenses which are included in prepaid and other assets. We have not advanced any cash to AMAK during 2019.

17. RELATED PARTY TRANSACTIONS

Consulting fees of approximately $28,000$32,000 and $19,000$25,000 were incurred during the three months and $50,000$82,000 and $50,000$75,000 during the sixnine months ended JuneSeptember 30, 2019 and 2018, respectively, from our Director, Nicholas Carter. Due to his history and experience with the Company and to provide continuity after his retirement, a three year consulting agreement was entered into with Mr. Carter in July 2015. In March 2019, a new consulting agreement was entered into with Mr. Carter effective through December 31, 2019, unless otherwise agreed by the Company and Mr. Carter.2019.

18. COMMITMENTS AND CONTINGENCIES

Guarantees

On October 24, 2010, we executed a limited Guaranteeguarantee in favor of the Saudi Industrial Development Fund ("SIDF") whereby we agreed to guaranty up to 41% of the SIDF loan (the "Loan") to AMAK in the principal amount of 330.0 million Saudi Riyals (US$88.0 million) (the "Loan"). The term of the loanLoan was originally through June 2019. As a condition of the Loan, SIDF required all stockholders of AMAK to execute personal or corporate Guarantees;guarantees; as a result, our guarantee is for approximately 135.3 million Saudi Riyals (US$36.1 million). The loanLoan was necessary to continue construction of the AMAK facilities and provide working capital needs. We received no consideration in connection with extending the guarantee and did so to maintain and enhance the value of our investment. On July 8, 2018, the SIDF loanLoan was amended to adjust the repayment schedule and extend the repayment terms through April 2024. Under the new payment terms the current amount due to SIDF in 2019 is 30.0 million Saudi Riyals (US$8.0 million). The total amount outstanding toon the SIDFLoan at JuneSeptember 30, 2019, was 290.0 million Saudi Riyals (US$77.3 million). See additional discussion including the release of the guarantee in connection with the AMAK sale in Note 19.

Operating Lease Commitments

See Note 8 for discussion on lease commitments.

Litigation

The Company is periodically named in legal actions arising from normal business activities. We evaluate the merits of these actions and, if we determine that an unfavorable outcome is probable and can be reasonably estimated, we will establish the

19




necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.


21




Supplier Agreements

From time to time, we may incur shortfall fees due to feedstock purchases being below the minimum amounts prescribed by our agreements with our suppliers. Shortfall fee expenses for the three months ended JuneSeptember 30, 2019, and 2018, were $0.1$0.3 million and $0.4$0.2 million, respectively, and for the sixnine months ended JuneSeptember 30, 2019, and 2018, were $0.7$0.3 million and $0.5$0.7 million, respectively.

Environmental Remediation

Amounts charged to expense for various activities related to environmental monitoring, compliance, and improvements were approximately $0.2 million and $0.2$0.1 million for the three months ended JuneSeptember 30, 2019, and 2018 and for the sixnine months ended JuneSeptember 30, 2019, and 2018, were $0.4$0.7 million and $0.3$0.4 million, respectively.

19. SUBSEQUENT EVENTS
Pursuant to a Share Sale and Purchase Agreement (the “Purchase Agreement”) that was effective as of October 2, 2019, the Company has agreed to sell its entire 33.3% equity interest in AMAK, to AMAK and certain other existing shareholders of AMAK (collectively, the “Purchasers”) for an aggregate gross purchase price (before taxes and transaction expenses) of SAR 264.7 million (or approximately US$70 million), which will be payable in US Dollars. The Purchasers have advanced 5% of the purchase price (or approximately $3.5 million) in the form of a non-refundable deposit, which was a condition to the effectiveness of the Purchase Agreement. As of September 30, 2019, deposits of approximately $2.2 million were received and recorded as a reduction in our investment in AMAK. The remainder of the deposits (approximately $1.3 million) were received subsequent to September 30, 2019.
The Purchase Agreement contains various representations, warranties and indemnity obligations of the Company and the Purchasers, including the release of the Company's guarantee as described in Note 18. The Purchase Agreement also contains certain termination rights of the Company, including if closing does not occur by November 25, 2019. The transaction is expected to close in the fourth quarter of 2019, subject to receipt of certain governmental approvals and other customary closing conditions.
On October 29, 2019 the Company experienced a severe weather event at the Specialty Petrochemicals facility in Silsbee, Texas, resulting in a plant shutdown and significant damage to one of the feedstock tanks. The plant returned to operation November 7, 2019. The Company is determining the financial impact of recovery costs and expects some loss of sales volumes.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

FORWARD LOOKING AND CAUTIONARY STATEMENTS

Some of the statements and information contained in this Quarterly Report on Form 10-Q may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements regarding the Company's financial position, business strategy and plans and objectives of the Company's management for future operations and other statements that are not historical facts, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as "outlook," "may," "will," "should," "could," "expects," "plans," "anticipates," "contemplates," "proposes," "believes," "estimates," "predicts," "projects," "potential," "continue," "intend," or the negative of such terms and other comparable terminology, or by discussions of strategy, plans or intentions.

Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Such risks, uncertainties and factors include, but are not limited to: general economic conditions domestically and internationally; insufficient cash flows from operating activities; difficulties in obtaining financing; outstanding debt and other financial and legal obligations; lawsuits; competition; industry cycles; feedstock, product and mineral prices; feedstock availability; technological developments; regulatory changes; environmental matters; foreign government instability; foreign legal and political concepts; foreign currency fluctuations; not completing, or not completely realizing the anticipated benefits from, the sale of our equity interest in AMAK; receipt and timing of necessary governmental approvals for the sale of our equity interest in AMAK; and other risks detailed in this report, in our latest Annual Report on Form 10–K, including but not limited to Part I, Item 1A. Risk Factors and Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations therein, and in our other filings with the SEC.

22




There may be other factors of which we are currently unaware or deem immaterial that may cause our actual results to differ materially from the forward-looking statements. In addition, to the extent any inconsistency or conflict exists between the information included in this report and the information included in our prior reports and other filings with the SEC, the information contained in this report updates and supersedes such information.

Forward-looking statements are based on current plans, estimates, assumptions and projections, and, therefore, you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them in light of new information or future events.

Overview

The following discussion and analysis of our financial results, as well as the accompanying unaudited consolidated financial statements and related notes to consolidated financial statements to which they refer, are the responsibility of our management. Our accounting and financial reporting fairly reflect our business model which is based on the manufacturing and marketing of specialty petrochemical products and waxes and providing custom manufacturing services.


20




The discussion and analysis of financial condition and the results of operations which appears below should be read in conjunction with the Management's Discussion and Analysis of Financial Condition and Results of Operations and the consolidated financial statements which appear in our Annual Report on Form 10-K for the year ended December 31, 2018.

Our preferred supplier position into the specialty petrochemicals market is derived from the combination of our reputation as a reliable supplier established over many years, the very high purity of our products, and a focused approach to customer service. In specialty waxes, we are able to deliver to our customers a performance and price point that is unique to our market; while the diversity of our custom processing assets and capabilities offers solutions to our customers that we believe are uncommon along the U.S. Gulf Coast.

Enabling our success in these businesses is a commitment to operational excellence which establishes a culture that prioritizes the safety of our employees and communities in which we operate, the integrity of our assets and regulatory compliance. This commitment drives a change to an emphasis on forward-looking, leading-indicators of our results and proactive steps to continuously improve our performance. We bring the same commitment to excellence to our commercial activities where we focus on the value proposition to our customers while understanding opportunities to maximize our value capture through service and product differentiation, supply chain and operating cost efficiencies and diversified supply options. We believe over time our focus on execution, meeting the needs of our customers and the prudent control of our costs will create value for our stockholders.

Review of SecondThird Quarter 2019 Results

We reported secondthird quarter 2019 net income of $2.4$0.6 million, up from net incomeloss of $2.2$1.6 million in the secondthird quarter of 2018. Diluted earnings per share are $0.10$0.02 for 2019, up from $0.09a loss per share of $(0.06) in 2018. Sales volume of our Specialty Petrochemicals products increased 8.7%decreased 4.8%, and sales revenue from our Specialty Petrochemicals products increased 4.4%decreased 13.6% as compared to the secondthird quarter 2018. Specialty Petrochemical sales volume declined due to lower Prime product Specialty Petrochemicals sales volumes (which exclude by-product sales) were up 10.2%which declined 3.0% compared to the secondthird quarter 2018. Specialty Waxes sales revenue was down 9.3%15.9% compared to the second quarter 2018. Consolidated gross profit margin increased to 15.2% of sales in the second quarter 2019 from 12.0% in the secondthird quarter 2018.

Consolidated Adjusted EBITDA from continuing operations was $4.9 million, for the secondthird quarter of 2019, was $9.2 million, representing a 13.3% margin compared with Consolidatedconsolidated Adjusted EBITDA from continuing operations of $6.2$3.1 million, or a 9.1% margin, in the secondthird quarter of 2018. Consolidated Adjusted EBITDA for the first quarter of 2019 was $8.4 million. Comparedfrom continuing operations increased due to the first quarter of 2019, Consolidated Adjusted EBITDA improved due tosubstantially better performance in our Specialty Waxes businessPetrochemicals segment as a result of lower feedstock costs, lower operating expenses and increased margin above feedstock for our by-products.improved plant operations. This was partially offset by higher natural gasoline feedstock costs which impacted prime products margins.weaker performance in our Specialty Waxes business.

Non-GAAP Financial Measures

We include in this Quarterly Report on Form 10-Q the non-GAAP financial measures of EBITDA from continuing operations and Adjusted EBITDA and Adjusted Net Income (Loss)from continuing operations and provide reconciliations from our most directly comparable GAAP financial measures to those measures.

We believe these financial measures provide users of our financial statements with supplemental information that may be useful in evaluating our operating performance. We also believe that such non–GAAPnon-GAAP measures, when read in conjunction

23




with our operating results presented under GAAP, can be used to better assess our performance from period to period and relative to performance of other companies in our industry, without regard to financing methods, historical cost basis or capital structure. These measures are not measures of financial performance or liquidity under GAAP and should be considered in addition to, and not as a substitute for, analysis of our results under GAAP.

EBITDA from continuing operations and Adjusted EBITDA:EBITDA from continuing operations: We define EBITDA from continuing operations as net income from continuing operations plus interest expense, including derivative gains and losses, income taxes, depreciation and amortization. We define Adjusted EBITDA from continuing operations as EBITDA from continuing operations plus stock-based compensation, plus restructuring and severance expenses, plus losses on extinguishment of debt, plus or minus equity in AMAK's earnings and losses or gains from equity issuances, and plus or minus gains or losses on acquisitions.

Adjusted Net Income (Loss): We define Adjusted Net Income (Loss) as net income (loss) plus or minus tax effected equity in AMAK's earnings and losses, minus tax effected restructuring and severance expenses, and adjustments for tax law changes.

21




The following table presents a reconciliation of net income (loss), our most directly comparable GAAP financial performance measure for each of the periods presented, to EBITDA from continuing operations and Adjusted EBITDA and Adjusted Net Income (Loss).from continuing operations.
 Three Months Ended
June 30, 2019
 Specialty Petrochemicals Specialty Waxes Corporate Consolidated
 (in thousands)
Net Income (Loss)$4,666
 $(1,013) $(1,249) $2,404
Interest1,053
 347
 1
 1,401
Taxes1,209
 
 (545) 664
Depreciation and amortization172
 24
 12
 208
Depreciation and amortization in cost of sales2,753
 1,375
 
 4,128
EBITDA9,853
 733
 (1,781) 8,805
Share-based compensation
 
 345
 345
Equity in losses of AMAK
 
 91
 91
Adjusted EBITDA$9,853
 $733
 $(1,345) $9,241
        
Net Income (Loss)$4,666
 $(1,013) $(1,249) $2,404
Equity in losses of AMAK
 
 91
 91
Taxes at statutory rate
 
 (19) (19)
Tax effected equity in losses
 
 72
 72
Adjusted Net Income (Loss)$4,666
 $(1,013) $(1,177) $2,476
 Three Months Ended
September 30, 2019
 Specialty Petrochemicals Specialty Waxes Corporate Consolidated
 (in thousands)
Net Income (Loss)$6,278
 $(2,071) $(3,626) $581
Loss from discontinued operations, net of tax
 
 (1,002) (1,002)
Income (Loss) from continuing operations$6,278
 $(2,071) $(2,624) $1,583
Interest895
 316
 
 1,211
Taxes803
 
 (565) 238
Depreciation and amortization171
 24
 13
 208
Depreciation and amortization in cost of sales1,729
 1,524
 1
 3,254
EBITDA from continuing operations$9,876
 $(207) $(3,175) $6,494
Stock-based compensation
 
 415
 415
Adjusted EBITDA from continuing operations$9,876
 $(207) $(2,760) $6,909
 Three Months Ended
June 30, 2018
 Specialty Petrochemicals Specialty Waxes Corporate Consolidated
 (in thousands)
Net Income2,928
 (506) (207) 2,215
Interest612
 281
 (78) 815
Taxes930
 
 (334) 596
Depreciation and amortization161
 22
 8
 191
Depreciation and amortization in cost of sales1,494
 1,343
 
 2,837
EBITDA6,125
 1,140
 (611) 6,654
Share-based compensation
 
 (220) (220)
Equity in earnings of AMAK
 
 (228) (228)
Adjusted EBITDA6,125
 1,140
 (1,059) 6,206
        
Net Income2,928
 (506) (207) 2,215
Equity in earnings of AMAK
 
 (228) (228)
Taxes at statutory rate
 
 48
 48
Tax effected equity in earnings
 
 (180) (180)
Adjusted Net Income (Loss)2,928
 (506) (387) 2,035
 Three Months Ended
September 30, 2018
 Specialty Petrochemicals Specialty Waxes Corporate Consolidated
 (in thousands)
Net Income (Loss)$2,504
 $(1,239) $(2,874) $(1,609)
Loss from discontinued operations, net of tax
 
 (893) (893)
Income (Loss) from continuing operations$2,504
 $(1,239) $(1,981) $(716)
Interest659
 265
 
 924
Taxes372
 
 (608) (236)
Depreciation and amortization165
 24
 16
 205
Depreciation and amortization in cost of sales2,486
 1,327
 
 3,813
EBITDA from continuing operations$6,186
 $377
 $(2,573) $3,990
Stock-based compensation
 
 630
 630
Loss on extinguishment of debt
 
 315
 315
Adjusted EBITDA from continuing operations$6,186
 $377
 $(1,628) $4,935

  
 2224 




 Six Months Ended
June 30, 2019
 Specialty Petrochemicals Specialty Waxes Corporate Consolidated
 (in thousands)
Net Income (Loss)10,808
 (3,552) (3,101) 4,155
Interest2,248
 651
 1
 2,900
Taxes2,203
 
 (1,061) 1,142
Depreciation and amortization341
 48
 32
 421
Depreciation and amortization in cost of sales5,658
 2,699
 
 8,357
EBITDA21,258
 (154) (4,129) 16,975
Share-based compensation
 
 558
 558
Equity in losses of AMAK
 
 150
 150
Adjusted EBITDA21,258
 (154) (3,421) 17,683
        
Net Income10,808
 (3,552) (3,101) 4,155
Equity in losses of AMAK
 
 150
 150
Taxes at statutory rate
 
 (32) (32)
Tax effected equity in losses
 
 118
 118
Adjusted Net Income (Loss)10,808
 (3,552) (2,983) 4,273
 Nine Months Ended
September 30, 2019
 Specialty Petrochemicals Specialty Waxes Corporate Consolidated
 (in thousands)
Net Income (Loss)$17,086
 $(5,623) $(6,727) $4,736
Loss from discontinued operations, net of tax
 
 (1,120) (1,120)
Income (Loss) from continuing operations$17,086
 $(5,623) $(5,607) $5,856
Interest3,143
 967
 1
 4,111
Taxes3,006
 
 (1,594) 1,412
Depreciation and amortization512
 72
 45
 629
Depreciation and amortization in cost of sales7,387
 4,223
 1
 11,611
EBITDA from continuing operations$31,134
 $(361) $(7,154) $23,619
Stock-based compensation
 
 973
 973
Adjusted EBITDA from continuing operations$31,134
 $(361) $(6,181) $24,592
 Six Months Ended
June 30, 2018
 Specialty Petrochemicals Specialty Waxes Corporate Consolidated
 (in thousands)
Net Income (Loss)7,898
 (1,687) (1,644) 4,567
Interest1,233
 537
 (77) 1,693
Taxes2,015
 
 (829) 1,186
Depreciation and amortization327
 44
 16
 387
Depreciation and amortization in cost of sales3,042
 2,625
 
 5,667
EBITDA14,515
 1,519
 (2,534) 13,500
Share-based compensation
 
 372
 372
Equity in earnings of AMAK
 
 (458) (458)
Adjusted EBITDA14,515
 1,519
 (2,620) 13,414
        
Net Income (Loss)7,898
 (1,687) (1,644) 4,567
Equity in earnings of AMAK
 
 (458) (458)
Taxes at statutory rate
 
 96
 96
Tax effected equity in earnings
 
 (362) (362)
Adjusted Net Income (Loss)7,898
 (1,687) (2,006) 4,205
 Nine Months Ended
September 30, 2018
 Specialty Petrochemicals Specialty Waxes Corporate Consolidated
 (in thousands)
Net Income (Loss)$10,402
 $(2,926) $(4,518) $2,958
Loss from discontinued operations, net of tax
 
 (531) (531)
Income (Loss) from continuing operations$10,402
 $(2,926) $(3,987) $3,489
Interest1,892
 802
 (77) 2,617
Taxes2,387
 
 (1,533) 854
Depreciation and amortization492
 68
 32
 592
Depreciation and amortization in cost of sales5,528
 3,952
 
 9,480
EBITDA from continuing operations$20,701
 $1,896
 $(5,565) $17,032
Stock-based compensation
 
 1,002
 1,002
Loss on extinguishment of debt
 
 315
 315
Adjusted EBITDA from continuing operations$20,701
 $1,896
 $(4,248) $18,349

Liquidity and Capital Resources

Working Capital

Our approximate working capital days are summarized as follows:

23




June 30, 2019
 December 31, 2018
 June 30, 2018
September 30, 2019
 December 31, 2018
 September 30, 2018
Days sales outstanding in accounts receivable41.1
 34.4
 34.3
35.5
 34.4
 38.1
Days sales outstanding in inventory20.6
 21.0
 22.0
18.4
 21.0
 22.8
Days sales outstanding in accounts payable15.0
 24.2
 15.4
14.1
 24.2
 17.0
Days of working capital46.6
 31.1
 40.8
39.8
 31.1
 43.9

Our days sales outstanding in accounts receivable at JuneSeptember 30, 2019 was 41.135.5 days compared to 34.4 days at December 31, 2018, driven by slightly higher Specialty Petrochemicals sales volumes toward the end ofin the quarter. Our days sales outstanding in inventory decreased by approximately 0.42.6 days from December 31, 2018. Our days sales outstanding in accounts payable decreased due to payment for the Advanced Reformer unit catalyst replacement which was completed in December 2018, severance payments and payment for supplemental wax feed. Since days of working capital is calculated using the above three metrics, it increased for the aforementioned reasons discussed.

25





Cash decreasedincreased $2.4 million during the sixnine months ended JuneSeptember 30, 2019, as compared to an increasea decrease of $0.4$1.7 million for the sixnine months ended JuneSeptember 30, 2018.

The change in cash is summarized as follows:
 Six Months Ended
June 30,
 Nine Months Ended
September 30,
 2019
 2018
 2019
 2018
Net cash provided by (used in) (thousands of dollars) (thousands of dollars)
Operating activities $5,848
 $9,798
 $20,249
 $11,110
Investing activities (3,842) (15,517) (4,254) (19,204)
Financing activities (4,416) 6,078
 (13,573) 6,358
(Decrease) Increase in cash $(2,410) $359
Increase (Decrease) in cash $2,422
 $(1,736)
Cash $4,325
 $3,387
 $9,157
 $1,292

Operating Activities
Cash provided by operating activities totaled $5.8$20.2 million for the first sixnine months of 2019, $4.0$9.1 million lowerhigher than the corresponding period in 2018. For the first sixnine months of 2019 net income decreasedincreased by approximately $0.4$1.8 million as compared to the corresponding period in 2018. Major non-cash items affecting 2019 income in the first sixnine months of 2019 included increases in deferred taxes of $0.9 million, depreciation and amortization of $8.8$12.3 million, deferred taxes of $1.3 million and stock-based compensation of $0.6$0.9 million. Major non-cash items affecting 2018 income in the first threenine months of 2018 included increases in deferred taxes of $1.1 million and depreciation and amortization of $4.9 million, and equity in earnings of AMAK of approximately $0.5$10.0 million.

FactorsAdditional factors leading to a decreasean increase in cash provided by operating activities included:

Depreciation and amortization was $7.9 million in the first six months of 2019, $2.9 million higher than the $4.9 million in the corresponding period of 2018. This was due to the completion of major capital projects.

Trade receivables increaseddecreased approximately $3.4$1.6 million. This was due to an increasea decrease in revenues in the secondthird quarter 2019 of $4.2$6.7 million, or nearly 6.5%9.6%, as compared with the firstsecond quarter 2019. Revenues in the secondthird quarter 2018 declined $3.1increased $5.3 million from the firstsecond quarter 2018.

Inventories decreased approximately $3.3 million driven by lower inventory in transit primarily due to lower sales to the Canadian oil sands and an overall decrease in value of inventory due to lower feedstock prices. Additionally, our Specialty Wax segment was constrained by disruptions of wax feed supply from a key supplier, resulting in increased sales of existing inventory.

In the second quarterfirst nine months of 2019, we did not have a change in taxes receivable. In the second quartersame period of 2018, we collected outstanding taxes receivable of $4.3 million related to prior periods and R&D credits.

Accounts payable and accrued liabilities decreased $6.8$6.0 million primarily due to payment for the Advanced Reformer unit catalyst replacement which was completed in December 2018, severance payments and payment for supplemental wax feed.

Investing Activities

24





Cash used in investing activities during the first sixnine months of 2019 was approximately $3.8$4.3 million, representing a decrease of approximately $11.7$15.0 million from the corresponding period of 2018. During the first sixnine months of 2019, the primary use of capital expenditures was for the sales rack and Advanced Reformer unit improvements and pipeline maintenance at SHR and equipment modifications at TC. This was offset by $1.3 million of proceeds received from AMAK for the repurchase of shares as discussed in Note 10 on our Annual Report on Form 10-K for the year ending December 31, 2018. In addition, $2.2 million related to the deposit was received in connection with the sale of our investment in AMAK discussed in Note 16. Our foreign tax liability resulting from AMAK's share repurchase program was $0.9 million. The cash to pay these taxes was withheld from the proceeds and paid directly by AMAK. As such, net cash received from AMAK was $0.4 million. During the first sixnine months of 2018, we had capital expenditures related to the hydrogenation/distillation unit and the Advanced Reformer unit along with various other facility improvements.


26




Financing Activities

Cash used in financing activities during the first sixnine months of 2019 was approximately $4.4$13.6 million versus cash provided by financing activities of $6.1$6.4 million during the corresponding period of 2018. During 2019, we made principal payments on our outstanding credit facilities of $6.2$15.3 million. We drew $2.0 million on our line of credit for working capital purposes during the first sixnine months of 2019. During 2018, we made principal payments on our acquisition loan of $3.5 million, our term debt of $0.7 million, and our line of credit facility of $6.0$8.1 million. We drew $16.0$18.2 million on our line of credit in the first sixnine months of 2018 to fund ongoing capital projects.

Subsequent to JuneSeptember 30, 2019, we made an optional principal payment of $4.0$5.0 million against the Revolving Facility, reducing the outstanding amount from $16.0$8.0 million to $12.0$3.0 million.

Anticipated Cash Needs

We believe that the Company is capable of supporting its operating requirements and capital expenditures through internally generated funds supplemented with borrowings under our ARC Agreement.


25





Results of Operations

Comparison of Three Months Ended JuneSeptember 30, 2019 and 2018

Specialty Petrochemicals Segment
 Three Months Ended June 30, Three Months Ended September 30,
 2019
 2018
 Change
 % Change
 2019
 2018
 Change
 % Change
 (thousands of dollars) (thousands of dollars)
Specialty Petrochemicals Product Sales $58,584
 $56,135
 $2,449
 4.4 % $53,277
 $61,675
 $(8,398) (13.6)%
Processing 1,527
 1,685
 (158) (9.4)% 1,208
 2,056
 (848) (41.2)%
Gross Revenue $60,111
 $57,820
 $2,291
 4.0 % $54,485
 $63,731
 $(9,246) (14.5)%
                
Volume of Sales (gallons)                
Specialty Petrochemicals Products 21,447
 19,733
 1,714
 8.7 % 20,523
 21,564
 (1,041) (4.8)%
Prime Product Sales 17,732
 16,092
 1,640
 10.2 % 16,431
 16,986
 (555) (3.3)%
                
Cost of Sales $50,049
 $50,738
 (689) (1.4)% $44,206
 $57,156
 (12,950) (22.7)%
Gross Margin 16.7% 12.2%   4.5 % 18.9% 10.3%   8.6 %
Total Operating Expense* 18,455
 17,081
 1,374
 8.0 % 17,248
 18,673
 (1,425) (7.6)%
Natural Gas Expense* 1,253
 1,328
 (75) (5.6)% 1,000
 1,265
 (265) (20.9)%
Operating Labor Costs* 3,596
 4,755
 (1,159) (24.4)% 3,619
 4,837
 (1,218) (25.2)%
Transportation Costs* 7,360
 7,082
 278
 3.9 % 6,997
 7,126
 (129) (1.8)%
General & Administrative Expense 2,816
 2,480
 336
 13.5 % 2,659
 2,893
 (234) (8.1)%
Depreciation and Amortization** 2,925
 1,655
 1,270
 76.7 % 1,900
 2,651
 (751) (28.3)%
Capital Expenditures 1,461
 3,529
 (2,068) (58.6)% 2,163
 2,562
 (399) (15.6)%
* Included in cost of sales
**Includes $2,753$1,729 and $1,494$2,486 for 2019 and 2018, respectively, which is included in operating expense

Gross Revenue

Gross Revenue for our Specialty Petrochemicals segment increaseddecreased during the secondthird quarter 2019 from the secondthird quarter 2018 by 4.0%,14.5% primarily due to an 8.7% increase4.8% decrease in sales volume; this was partially offset byvolume, a 4%9.2% decline in average selling price due mainly to lower feedstock costs.costs and lower processing revenues.


27




Specialty Petrochemicals Product Sales

Specialty Petrochemicals product sales increaseddeclined approximately 4.4%13.6% during the secondthird quarter 2019 from the secondthird quarter 2018 mainly due mainly to growth in prime products sales volume to the Canadian oil sands. This was partially offset by lower average selling priceproduct prices for prime products which wasand by-products. Lower prices were primarily driven by lower feedstock costs. Prime product sales volume grew approximately 10.2%declined about 3.3% compared to the third quarter of 2018. Compared to the second quarter of 2018 and were flat from the first quarter of 2019. It is not clear that the increase in2019 prime product volume declined about 7.3% or about 1.3 million gallons primarily due to lower sales volume to the Canadian oil sands, will continue forand an unplanned outage at a major customer. The sales outlook to the remainder of 2019Canadian oil sands continues to remain uncertain due to the uncertainty around government mandated crude production curtailments in Canada and the crude oil pricing environment. Also, we expect a decline in sales demand due to typical market seasonality in many of end-use markets.

By-product sales volumes were flatin third quarter 2019 declined 10.6% from thethird quarter 2018. By-product sales volume increased 10.1% from second quarter 2018 and declined about 23% from the first quarter of 2019. The decline in by products sales from the first quarter of 2019 was due to changean increase in the feed mix to the Advanced Reformer unit which produces by-products. This change inIn the second quarter 2019 feed mixto the Advanced Reformer was donediverted to maximize prime product production.production to meet certain customer needs . It should be noted that by-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume increased to 24.7%22.4% of total Specialty Petrochemicals volume in the third quarter of 2019, from 21.5% in the secondthird quarter 2018.

26



Foreign sales volume includes sales to the Canadian oil sands.

Processing

Processing revenues decreased 9.4%approximately $0.8 million or 41.2% in the secondthird quarter 2019 from the secondthird quarter 2018 primarily due to the termination of a customer contract in the fourth quarter 2018.

Cost of Sales

We use natural gasoline as feedstock, which is the heavier liquid remaining after ethane, propane and butanes are removed from liquids produced by natural gas wells. The material is a commodity product in the oil/petrochemical markets and generally is readily available. The price of natural gasoline is highly correlated with the price of crude oil. Our Advanced Reformer unit upgrades the by-product stream produced as a result of prime product production. This upgrade allows us to sell our by-products at higher prices than would be possible without the Advanced Reformer unit.

Cost of Sales declined 1.4%22.7% during the secondthird quarter 2019 from the secondthird quarter in 2018. The decline of $0.7approximately $13 million in cost of sales was largely due to lower feedstock and operating labor costs, partially offset by higher depreciation and amortization and other expenses.costs. Benchmark Mount Belvieu natural gasoline feedstock price declined 31% from $1.54 per gallon in the third quarter of 2018 to $1.06 per gallon in the third quarter of 2019. Compared to the second quarter of 2019 benchmark Mount Belvieu natural gasoline feedstock price for the third quarter 2019 declined 12%. Natural gasoline feedstock pricing historically has been volatile. Our average delivered feedstock cost per gallon declined 20% compared to the second quarter of 2018 due to an approximately 22% drop in the benchmark price of Mont Belvieu natural gasoline. Our average feedstock cost for the second quarter 2019 was down approximately 4% from the first quarter of 2019. During the course of the second quarter of 2019, feedstock costs have steadily declined month by month. We sell our prime products under both formula-based pricing, where feedstock costs are passed through to the customer, and spot or non-formula-based pricing, which do not have pricing formulas tied to feedstock costs. Formula-based pricing is used to sell the majority of our prime products. Additionally, we cost our inventory on FIFO basis. As a result, in a declining feedstock market our margins are negatively impacted.

The gross margin percentage for the Specialty Petrochemicals Segment increased from 12.2%10.3% in the secondthird quarter of 2018 to 16.7%18.9% in the secondthird quarter of 2019 driven by lower cost of salesfeedstock costs, lower operating expenses and improved margins over feed for by-products due to the operation of the Advanced Reformer unit.by-products.

Total Operating Expense

Total Operating Expense increaseddecreased $1.4 million, or 8.0%7.6%, during the secondthird quarter 2019 from 2018. TheThere were several key drivers for the increase were higher depreciation and amortization related to the Advanced Reformer unit, which was not operational in the second quarter 2018, and higher outside contractdecrease, including lower labor costs, relatedlower natural gas costs and lower transportation costs. Labor costs were lower mainly due to maintenance turnarounds that were completed in the second quarter of 2019. This was partly offset by $1.1 million in lower operating labor costs, mainly resulting from the cost reduction program implemented at SHR in December 2018.

Capital Expenditures

Capital expenditures in the secondthird quarter 2019 were approximately $1.5$2.2 million compared to $3.5$2.6 million in the secondthird quarter of 2018. This was primarily due toFollowing the completion of the Advanced Reformer unit in 2018. Capital expenditures in the second quarter 2018 included capital expenditures to complete the construction of the Advanced Reformer unit.


27




Specialty Waxes Segment
  Three Months Ended June 30,
  2019
 2018
 Change
 % Change
  (thousands of dollars)
Product Sales $6,745
 $7,434
 $(689) (9.3)%
Processing 2,515
 2,852
 (337) (11.8)%
Gross Revenue $9,260
 $10,286
 $(1,026) (10.0)%
         
Volume of specialty wax sales (thousand pounds) 9,955
 10,544
 (589) (5.6)%
         
Cost of Sales $8,757
 $9,225
 $(468) (5.1)%
Gross Margin 5.4% 10.3%   (4.9)%
General & Administrative Expense 1,083
 1,239
 (156) (12.6)%
Depreciation and Amortization* 1,399
 1,365
 34
 2.5 %
Capital Expenditures $426
 $877
 $(451) (51.4)%
*Includes $1,375 and $1,343 for 2019 and 2018, respectively, which is included in cost of sales

Product Sales

Product sales revenue decreased 9.3% during the second quarter 2019 from the second quarter 2018 as specialty wax sales volume declined 5.6%. Wax sales were constrained by production in the second quarter of 2019 due to disruptions of wax feed supply from our suppliers. Our wax feed is based on certain by-products produced as a result of polyethylene production at major polyethylene producers' facilities on the US Gulf Coast. In addition, in the second quarter of 2018, we had one-time sales of off-spec material of approximately 350,000 pounds. Customer demand continues to be strong for our higher value specialty waxes including our products used in the Hot Melt Adhesives ("HMA")capital expenditures mainly include routine plant maintenance and PVC Lubricant markets. These products are characterized by generally higher marginsenvironmental, health and growth rates.

Processing

Processing revenues declined 11.8% during the second quarter 2019 from the second quarter 2018. The decrease, among other factors, is due to minimal processing revenues from the hydrogenation/distillation unit. The unit was down for a significant part of this quarter as we worked on improving the unit's ability to operate effectively and reliably. Excluding the impact of the hydrogenation/distillation unit custom processing, revenues in the second quarter of 2019 were about flat from the same quarter of 2018.

Cost of Sales

Cost of Sales were relatively flat in the second quarter 2019 from the second quarter 2018.

Depreciation

Depreciation increased $0.3 million or 2.5% during the second quarter 2019 from 2018.

Capital Expenditures

Capital Expenditures were approximately $0.4 million in the second quarter 2019 compared with $0.9 million in the second quarter of 2018.
safety (EH&S) projects.


  
 28 




Specialty Waxes Segment
  Three Months Ended September 30,
  2019
 2018
 Change
 % Change
  (thousands of dollars)
Product Sales $5,834
 $6,938
 $(1,104) (15.9)%
Processing 2,396
 2,799
 (403) (14.4)%
Gross Revenue $8,230
 $9,737
 $(1,507) (15.5)%
         
Volume of specialty wax sales (thousand pounds) 8,649
 9,055
 (406) (4.5)%
         
Cost of Sales $8,879
 $9,470
 $(591) (6.2)%
Gross Margin (Loss) (7.9)% 2.7%   (10.6)%
General & Administrative Expense 1,071
 1,180
 (109) (9.2)%
Depreciation and Amortization* 1,548
 1,351
 197
 14.6 %
Capital Expenditures $361
 $1,094
 $(733) (67.0)%
*Includes $1,524 and $1,327 for 2019 and 2018, respectively, which is included in cost of sales

Product Sales

For the Specialty Wax Segment Product sales revenue decreased 15.9% during the third quarter 2019 from the third quarter 2018 as specialty wax sales volume declined 4.5%. Wax sales were constrained by disruptions of wax feed supply from a key suppliers as they experienced their own operating difficulties. Our wax feed is based on certain by-products produced as a result of polyethylene production at major polyethylene producers' facilities on the US Gulf Coast. Customer demand in the third quarter was strong and our sales remained limited by wax feed supply.

Processing

Processing revenues declined 14.4% or about $0.4 million during the third quarter 2019 from the third quarter 2018. The decrease was due to lower revenues from the hydrogenation/distillation unit as we work to improve the unit's reliability and lower demand from certain custom processing customers.

Cost of Sales

Cost of Sales were lower in the third quarter 2019 from the third quarter 2018 due to lower wax sales.

Depreciation

Depreciation for the third quarter 2019 was $1.49 million relatively flat from third quarter 2018.

Capital Expenditures

Capital Expenditures were approximately $0.4 million in the third quarter 2019 compared with $1.1 million in the third quarter of 2018.

Corporate Segment
  Three Months Ended June 30,
  2019
 2018
 Change
 % Change
  (thousands of dollars)  
General & Administrative Expense $2,182
 $834
 $1,348
 161.6 %
Equity in (losses) earnings of AMAK (91) 228
 (319) (139.9)%

General and Administrative Expenses
  Three Months Ended September 30,
  2019
 2018
 Change
 % Change
  (thousands of dollars)  
General & Administrative Expense $2,670
 $2,252
 $418
 18.6%

General corporate expenses increased during the secondthird quarter 2019 from the secondthird quarter 2018. The increase is primarily attributable to the second quarter 2018 cancellation and reversal of stockan increase in executive compensation expense and other post-retirement benefits totaling approximately $1.5 million previously awarded to Mr. Hatem El Khalidi.accrual.

Equity
29




Investment in Earnings (Losses) of AMAK - Discontinued Operations

  Three Months Ended September 30,
  2019
 2018
 Change
 % Change
  (thousands of dollars)  
Equity in (losses) earnings of AMAK $(1,268) $(1,130) $(138) 12.2%

Equity in earnings (losses) of AMAK decreased during the secondthird quarter 2019 from the secondthird quarter 2018. The equity in earnings (losses) were impacted by increased cost of salesselling, general and Zakat and income taxes.administrative expenses.

AMAK Summarized Income Statement

 Three Months Ended
June 30,
 Three Months Ended
September 30,
 2019 2018 2019 2018
 (thousands of dollars) (thousands of dollars)
Sales $20,566
 $19,494
 $19,643
 $19,877
Cost of sales 18,162
 16,555
 19,072
 20,350
Gross profit 2,404
 2,939
 571
 (473)
Selling, general, and administrative 2,807
 2,892
 3,557
 2,736
Operating (loss) income (403) 47
 (2,986) (3,209)
Other (expense) income (75) 15
 43
 35
Finance and interest expense (448) (388) (456) (416)
Loss before Zakat and income taxes (926) (326) (3,399) (3,590)
Zakat and income taxes 366
 
 444
 800
Net Loss $(1,292) $(326) $(3,843) $(4,390)
        
Finance and interest expense 448
 388
 456
 416
Depreciation and amortization 7,746
 8,281
 8,534
 8,899
Zakat and income taxes 366
 
 444
 800
EBITDA $7,268
 $8,343
 $5,591
 $5,725

AMAK continued to make progress in throughput rates, concentrate quality and recoveries. Approximately 17,00018,000 dry metric tons (dmt) of copper and zinc concentrate were shipped in the secondthird quarter 2019 as compared to 14,00017,000 dmt of copper and zinc concentrate in the secondthird quarter 2018. SecondThird quarter EBITDA declinedwas approximately $1.1$5.6 million, relatively flat compared to the secondthird quarter 2018 primarily due to increased cost of sales resulting from a change in inventory valuation methodology and one-time non-recurring expenses.2018.
















30




Comparison of SixNine Months Ended JuneSeptember 30, 2019 and 2018

Specialty Petrochemicals Segment
 Six Months Ended June 30, Nine Months Ended September 30,
 2019
 2018
 Change
 % Change
 2019
 2018
 Change
 % Change
 (thousands of dollars) (thousands of dollars)
Specialty Petrochemicals Product Sales 114,074
 116,420
 $(2,346) (2.0)% 167,351
 178,094
 $(10,743) (6.0)%
Processing 2,910
 3,713
 (803) (21.6)% 4,117
 5,769
 (1,652) (28.6)%
Gross Revenue $116,984
 $120,133
 $(3,149) (2.6)% $171,468
 $183,863
 $(12,395) (6.7)%
                
Volume of Sales (gallons)                
Specialty Petrochemicals Products 43,915
 43,022
 893
 2.1 % 64,438
 64,586
 (148) (0.2)%
Prime Product Sales 35,370
 33,742
 1,628
 4.8 % 51,801
 50,729
 1,072
 2.1 %
                
Cost of Sales 95,915
 103,387
 (7,472) (7.2)% 140,121
 160,543
 (20,422) (12.7)%
Gross Margin 18.0% 13.9%   4.1 % 18.3% 12.7%   5.6 %
Total Operating Expense* 36,735
 32,924
 3,811
 11.6 % 53,983
 51,597
 2,386
 4.6 %
Natural Gas Expense* 2,636
 2,576
 60
 2.3 % 3,636
 3,841
 (205) (5.3)%
Operating Labor Costs* 7,299
 8,514
 (1,215) (14.3)% 10,918
 13,351
 (2,433) (18.2)%
Transportation Costs* 14,408
 14,402
 6
  % 21,405
 21,528
 (123) (0.6)%
General & Administrative Expense 5,291
 5,300
 (9) (0.2)% 7,950
 8,193
 (243) (3.0)%
Depreciation and Amortization** 5,999
 3,369
 2,630
 78.1 % 7,899
 6,020
 1,879
 31.2 %
Capital Expenditures 2,839
 13,812
 (10,973) (79.4)% 5,002
 16,374
 (11,372) (69.5)%
* Included in cost of sales
**Includes $5,658$7,387 and $3,042$5,528 for 2019 and 2018, respectively, which is included in operating expense

Gross Revenue

Gross Revenue for our Specialty Petrochemicals segment decreased during the first halfnine months of 2019 from the first halfnine months of 2018 by 2.6%6.7% primarily due to a decrease in the average selling price of Specialty Petrochemicals products of 4.0%5.8% and lower processing revenue of $0.8$1.7 million. These two factors were partially offset by a 2.1% increase in Specialty Petrochemicals sales volume.

Specialty Petrochemicals Product Sales

Revenues from Specialty Petrochemicals product sales decreased 2.0%6.0% during the first halfnine months of 2019 from the first halfnine months of 2018. This was primarily due to a 4.0%5.8% decrease in average selling price as a result of lower feedstock pricing, which was partially offset by a 2.1% increase in sales volumes.pricing. Prime product sales volumes were up 4.8%,2.1% or approximately 1.61.1 million gallons infor the first halfnine months of 2019 due to continued solid demand in the polyethylene and polyurethane markets. Sales volumes to the Canadian oil sands market were up 51% as compared to the first half ofsame period in 2018. It is not clear that theThe increase in sales volume was mainly due to the Canadiana large sale for supplier qualification at an oil sands will continue for the remainder of 2019 due to the uncertainty around government mandated crude production curtailments in Canada and the crude oil pricing environment.customer. Average selling prices decreased as prices for both prime products and by-products declined in concert with lower feedstock costs. Average feedstock costs inBy-product margins increased for the first half of 2019 were approximately 20% less than the first half of 2018. Although by-product prices were somewhat lower in the firstnine months of 2019 compared to first halfnine months of 2018 by-product margins were significantly higher. This was theprimarily as a result of steady and reliable operation of the Advanced Reformer unit which upgrades the by-product stream to higher value chemical products that are sold at higher prices than would be possible without the Advanced Reformer unit. By-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume increased to 24.9%24.1% of total Specialty Petrochemicals volume from 23.0% in the first halfnine months of 2018.

Processing

Processing revenues decreased $0.8$1.7 million or 21.6%28.6% in the first halfnine months of 2019 from the first halfnine months of 2018 due to the termination of a customer contract in the fourth quarter 2018.

Cost of Sales


  
 2931 




Cost of Sales

Cost of Sales declined 7.2%12.7% during the first halfnine months of 2019 from the first halfnine months of 2018 primarily due to the decrease in feedstock cost. Our averageFor the first nine months of 2019 compared with the same period in 2018, benchmark Mount Belvieu natural gasoline feedstock costprice declined 24% from approximately $1.49 per gallon declined approximately 20% compared to the first half of 2018 due to an approximately 20% drop in the benchmark price of Mont Belvieu natural gasoline.$1.13 per gallon. We sell our prime products under both formula-based pricing where feedstock costs are passed through to the customer and spot or non-formula based pricing which do not have pricing formulas tied to feedstock costs. Formula-based pricing is used to sell the majority of our prime products.

The gross margin percentage for the Specialty Petrochemicals Segment increased from 13.9%12.7% in the first halfnine months of 2018 to 18.0%18.3% in the first halfnine months of 2019 driven by lower feedstock costs resulting in better product margins, significantly higher by-product margins primarily due to more reliable operation of the Advanced Reformer unit and lower labor costs as a result of the cost reduction program implemented at SHR in December 2018.

Total Operating Expense

Total Operating Expense increased 11.6%4.6% during the first halfnine months of 2019 from 2018.  A 14.3%, or $1.2 million, reduction in operatingLower labor costs wasand lower other operating expenses were more than offset by $2.6$1.9 million increase in depreciation and amortization related to the Advanced Reformer unit which was not operationalcame on line in the first halfthird quarter of 2018.

Capital Expenditures

Capital Expenditures in the first halfnine months of 2019 were approximately $2.8$5.0 million compared to $13.8$16.4 million in the first halfnine months of 2018. The bulk of 2019 capital expenditures were related to modifications and improvements to the Advanced Reformer unit and natural gasoline feedstock pipeline maintenance work as compared to the 2018 Advanced Reformer capital project in the first half of 2018.work.

Specialty Waxes Segment
 Six Months Ended June 30, Nine Months Ended September 30,
 2019
 2018
 Change
 % Change
 2019
 2018
 Change
 % Change
 (thousands of dollars) (thousands of dollars)
Product Sales $12,748
 $13,817
 $(1,069) (7.7)% $18,582
 $20,755
 $(2,173) (10.5)%
Processing 4,794
 6,064
 (1,270) (20.9)% 7,191
 8,863
 (1,672) (18.9)%
Gross Revenue $17,542
 $19,881
 $(2,339) (11.8)% $25,773
 $29,618
 $(3,845) (13.0)%
                
Volume of specialty wax sales (thousand pounds) 17,837
 20,085
 (2,248) (11.2)% 26,486
 29,140
 (2,654) (9.1)%
                
Cost of Sales $17,973
 $18,344
 $(371) (2.0)% $26,852
 $27,814
 $(962) (3.5)%
Gross Margin (2.5)%
7.7%   (10.2)%
Gross Margin (Loss) (4.2)%
6.1%   (10.3)%
General & Administrative Expense 2,352
 2,607
 (255) (9.8)% 3,423
 3,787
 (364) (9.6)%
Depreciation and Amortization* 2,747
 2,669
 78
 2.9 % 4,295
 4,020
 275
 6.8 %
Capital Expenditures $935
 $1,622
 $(687) (42.4)% $1,296
 $2,716
 $(1,420) (52.3)%
*Includes $2,699$4,223 and $2,625$3,952 for 2019 and 2018, respectively, which is included in cost of sales

Product Sales

Product sales revenue decreased 7.7%10.5% during the first halfnine months of 2019 from the first halfnine months of 2018 as specialty wax sales volume declined 11.2%9.1%. Planned maintenance turnaround at our Pasadena facility in the first quarter of 2019, along with outages at multiple wax feed suppliers, constrained specialty wax production and thereby sales. In addition, the second quarter ofin 2018 sales benefited from one-time sales of off-spec material. Our average Specialty Waxes selling price increased 3% fromproduct that did not meet customer specifications. Customer demand during the first halfnine months of 2018, reflecting2019 was strong and our marketing strategy to enhance pricing. Customer demand continues to be strong for our higher value specialty waxes including our products for the Hot Melt Adhesives and PVC Lubricant markets. These products are characterizedsales remained limited by generally higher margins and growth rates. We successfully used the hydrogenation/distillation unit to upgrade certain wax products. We believe this will help to drive growth in targeted higher-value markets.



feed supply.


  
 3032 




Processing

Processing revenues declined approximately $1.3$1.7 million during the first halfnine months of 2019 from the first halfnine months of 2018. The decrease was partially due to lower revenues from the hydrogenation/distillation unit as we work to improve the unit's reliability. Additionally, we saw reducedreliability and lower demand from somecertain custom processing customers.

Cost of Sales

Cost of Sales decreased 2.0%3.5% or approximately $1.0 million during the first halfnine months of 2019 from the first half of 2018. Operating expenses including costs for labor, maintenance, and utilities declined 3% from the first halfnine months of 2018 as the facility focused on reducing expenses as it works to improve plant reliabilitya result of lower wax sales and efficiency.lower operating expenses.

Depreciation

Depreciation increased 2.9%6.8% during the first halfnine months of 2019 from the first halfnine months of 2018.

Capital Expenditures

Capital Expenditures were approximately $0.9$1.3 million in the first halfnine months of 2019 compared with $1.6$2.7 million in the first halfnine months of 2018.

Corporate Segment
  Six Months Ended June 30,
  2019
 2018
 Change
 % Change
  (thousands of dollars)  
General & Administrative Expense $4,487
 $2,982
 $1,505
 50.5 %
Equity in (losses) earnings of AMAK (150) 458
 (608) (132.8)%

General and Administrative Expenses
  Nine Months Ended September 30,
  2019
 2018
 Change
 % Change
  (thousands of dollars)  
General & Administrative Expense $7,159
 $5,234
 $1,925
 36.8%

General corporate expenses increased approximately $1.9 million during the first halfnine months of 2019 from the first halfnine months of 2018. The increase is primarily attributable to the second quarter 2018 cancellation and reversal of stock compensation expense and other post-retirement benefits totaling approximately $1.5 million previously awarded to Mr. Hatem El Khalidi.

EquityInvestment in Earnings (Losses) of AMAK - Discontinued Operations

  Nine Months Ended September 30,
  2019
 2018
 Change
 % Change
  (thousands of dollars)  
Equity in (losses) earnings of AMAK (1,418) (672) (746) 111.0%

Equity in earnings (losses) of AMAK decreased during the first halfnine months of 2019 from the first halfnine months of 2018. The equity in earnings (losses) were impacted by increased selling, general and administrative expenses.


  
 3133 




AMAK Summarized Income Statement

 Six Months Ended
June 30, 2019
 Nine Months Ended
September 30, 2019
 2019 2018 2019 2018
 (thousands of dollars) (thousands of dollars)
Sales $41,230
 $33,581
 $60,873
 $53,458
Cost of sales 36,732
 29,061
 55,804
 49,411
Gross profit 4,498
 4,520
 5,069
 4,047
Selling, general, and administrative 5,545
 4,415
 9,102
 7,151
Operating income (loss) (1,047) 105
 (4,033) (3,104)
Other income 353
 34
 396
 70
Finance and interest expense (893) (785) (1,349) (1,201)
Loss before Zakat and income taxes (1,587) (646) (4,986) (4,235)
Zakat and income taxes 888
 
 1,332
 800
Net Loss $(2,475) $(646) $(6,318) $(5,035)
        
Finance and interest expense 893
 785
 1,349
 1,201
Depreciation and amortization 15,070
 15,982
 23,604
 24,881
Zakat and income taxes 888
 
 1,332
 800
EBITDA $14,376
 $16,121
 $19,967
 $21,847


AMAK continued to make progress in throughput rates, concentrate quality and recoveries. Approximately 31,00049,000 dry metric tons (dmt) of copper and zinc concentrate were shipped in the first halfnine months of 2019 as compared to 27,00042,000 dmt of copper and zinc concentrate in the first halfnine months of 2018. EBITDA shows a decline of approximately $1.7$1.9 million compared to the first halfnine months of 2018 primarily due to increased cost of sales resulting from a change in inventory valuation methodology and one-time non-recurring expenses.

Contractual Obligations

Our contractual obligations are summarized in Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations," in our Annual Report on Form 10-K for the year ended December 31, 2018. See Note 10 for changes to our debt maturity schedule. There have been no other material changes to the contractual obligation amounts disclosed in our Annual Report on Form 10-K for the year ended December 31, 2018.

Critical Accounting Policies and Estimates

Critical accounting policies are more fully described in Note 2, “Summary of Significant Accounting Policies” to the consolidated financial statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2018. The preparation of consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the period reported. By their nature, these estimates, assumptions and judgments are subject to an inherent degree of uncertainty. We base our estimates, assumptions and judgments on historical experience, market trends and other factors that are believed to be reasonable under the circumstances. Estimates, assumptions and judgments are reviewed on an ongoing basis and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Actual results may differ from these estimates under different assumptions or conditions. Our critical accounting policies and estimates have been discussed with the Audit Committee of the Board of Directors and discussed in our Annual Report on Form 10-K for the year ended December 31, 2018. For the sixnine months ended JuneSeptember 30, 2019, there were no significant changes to these policies except for the policies related to the accounting for leases as a result

  
 3234 




leases as a result of the adoption of ASU 2016-02, Leases, as of January 1, 2019 as described in Note 1 – General and Note 8 – Leases in the accompanying condensed consolidated financial statements.

Recent and New Accounting Standards

See Note 1 and 2 to the Consolidated Financial Statements for a summary of recent accounting guidance.

Off Balance Sheet Arrangements

Off balance sheet arrangements as defined by the SEC means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with the registrant is a party, under which the registrant has (i) obligations under certain guarantees or contracts, (ii) retained or contingent interest in assets transferred to an unconsolidated entity or similar arrangements, (iii) obligations under certain derivative arrangements, and (iv) obligations arising out of a material variable interest in an unconsolidated entity. Our guarantee for AMAK's debt is considered an off balance sheet arrangement. Please see further discussion under "Investment in AMAK" in NoteNotes 16 and 19 to the Condensed Consolidated Financial Statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

For quantitative and qualitative disclosure about market risk, see Part II, Item 7A, Quantitative and Qualitative Disclosures about Market Risk in our Annual Report on Form 10–K for the year ended December 31, 2018. There have been no material changes in the Company's exposure to market risk from the disclosure included in such report.

ITEM 4. CONTROLS AND PROCEDURES.

(a)
Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Chief Financial Officer, with the participation of management, have evaluated the effectiveness of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15(d)-15(e) under the Securities Exchange Act of 1934) and determined that our disclosure controls and procedures were effective as of the end of the period covered by this report.

(b)
Changes in internal control. There were no significant changes in our internal control over financial reporting that occurred during the sixthree months ended JuneSeptember 30, 2019, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

  
 3335 




PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is periodically named in legal actions arising from normal business activities. The Company evaluates the merits of these actions and, if it determines that an unfavorable outcome is probable and can be reasonably estimated, the Company will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.

ITEM 1A. RISK FACTORS.

Readers of this Quarterly Report on Form 10–Q should carefully consider the risks described in the Company's other reports and filings filed with or furnished to the SEC, including the Company's prior and subsequent reports on Forms 10–K, 10–Q and 8–K, in connection with any evaluation of the Company's financial position, results of operations and cash flows.

The risks and uncertainties in the Company's most recent Annual Report on Form 10–K are not the only risks that the Company faces. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect the Company's operations. Any of the risks, uncertainties, events or circumstances described therein could cause the Company's future financial condition, results of operations or cash flows to be adversely affected. There have been no material changes from the risk factors previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.2018, except as noted below.

Consummation of the sale of the Company's equity interest in AMAK is subject to a number of closing conditions, including receipt certain governmental approvals, that may not be satisfied, and the closing of the sale may be delayed or the sale may not be completed as contemplated, or at all.
Although we have entered into the Purchase Agreement with respect to the sale of the Company's equity interest in AMAK to the Purchasers, we cannot guarantee when, or whether the sale will be completed. The closing of the sale is subject to closing conditions, including the receipt of certain governmental approvals from the Saudi Arabian Deputy Ministry for Mineral Resources and the SIDF (with respect to release of the Company's limited guarantee of the Loan (as described in Note 18)). If the closing conditions are not satisfied or waived (to the extent any such condition may be waived), in either a timely manner or at all, the closing of the sale may be delayed or may not be completed as contemplated, or at all, which could cause us not to realize some or all of the anticipated benefits of the transaction. In addition, the market price of the Company's common stock may reflect an assumption that the pending sale will occur and on a timely basis, and the failure to do so may result in a decline in the market price of the Company's common stock.

  
 3436 




ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Unregistered Sales of Equity Securities

In connection with certain amendments to his Employment Contract, Peter M. Loggenberg, our Chief Sustainability Officer, was granted 4,400 restricted shares of our common stock on February 21, 2019.  The restricted shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, and vest in equal increments over a three year period.

Issuer Purchases of Equity Securities
Period
(a)
Total Number of Shares (or Units) Purchased(1)

 
(b)
Average Price Paid Per Share (or Unit)(1)

 
(c)
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs

 
(d)
Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs

April 1, 2019 - April 30, 2019
 $
 
 
May 1, 2019 - May 31, 2019
 
 
 
June 1, 2019 - June 30, 20192,107
 9.81
 
 
Total2,107
 $9.81
 
 
(1) Represents shares of our common stock withheld for satisfaction of tax liabilities of a holder of restricted shares. The value of such shares was calculated based on the closing price of our common stock on the New York Stock Exchange on the date when the withholding was made.

ITEM 6. EXHIBITS.

The following documents are filed or incorporated by reference as exhibits to this Report. Exhibits marked with an asterisk (*) are filed herewith and exhibits marked with a double asterisk (**) are furnished herewith. Exhibits marked with a plus sign (+) are compensatory plans.


Exhibit
Number
Description
10.1*+2.1*
31.1*
31.2*
32.1**
32.2**
101.INS*XBRL Instance Document
101.SCH*XBRL Taxonomy Schema Document
101.CAL*XBRL Taxonomy Calculation Linkbase Document
101.LAB*XBRL Taxonomy Label Linkbase Document
101.PRE*XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF*XBRL Taxonomy Extension Definition Linkbase Document



  
 3537 




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 TRECORA RESOURCES
   
Dated: AugustNovember 8, 2019By: /s/ Sami Ahmad
  Sami Ahmad
  Principal Financial Officer and Duly Authorized Officer


  
 3638